• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/498

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

498 Cards in this Set

  • Front
  • Back
Orthomyxoviruses
3 types:
-Influenza A: infects humans and other species
--can cause pandemics
--Most common type of influenza
-Influenza B: restricted to humans
-Influenza C: Mostly restricted to humans
--less common
Human Influenza Pandemics in the 20th century
-1918: Spanish Flu, 20-40 million deaths
--H1N1
-1957: Asian Flu 1-4 million deaths
--H1N2
-1968: Hong Kong Flu 1-4 million deaths
--H3N2
-Swine Flu, 18,000 deaths
--H1N1
--young people wit weaker immune systems
Spanish Influenza
-Orthomyxovirus
-H1N1 type virus
-Affected middle aged and younger people
-over 30 million deaths
-War contributed to close contact and easy transmission of disease
Influenza Virus Nomenclature
Type / Species / Location / Number of isolate / year isolated

-Serotypes are based on surface proteins
Influenza Virus microscopy
-Can see proteins on surface of the virus
Influenza A virus Key features
- 100nm large
- Enveloped virus, carries part of cell membrane
-Genome is segmented negative strand RNA
-8 genomic segments
-10 genes total
--not the smallest virus, but pretty darn small
-Each genome segment forms a ribonucleoprotein (RNP)
-Transcription and replication occur in the nucleus
-Translation and protein synthesis occurs in the cytoplasm
Influenza Virus eclipse period
1. Virus binds to cell surface receptors
2. Endosome is formed around enveloped virus
3. Virus membrane/envelope and endosome fuse
--viral negative sense RNA is released into the cytosol
4. Viral RNA enters the nucleus and is replicated
-mRNA synthesis and RNA replication occurs in the nucleus
-Proteins are translated and synthesized in cytoplasm
5. Viral genome buds with late proteins to form enveloped virus
Ribonucleoprotein
RNP
-Negative-sense single-stranded RNA with 3 polymerase subunits
-Genomic organization of influenza virus
-Influenza RNA is ALWAYS part of complex with ribonucleoproteins
--unstable as RNA alone
Influenza A virus genome shuffling
-Segmented genome allows for reassortment of genomic segments
-Can cause major changes in subtype
-Form of antigenic shift
-Allows influenza virus to change and jump from species to species
-All segmented viruses undergo antigenic shift
--8 segments of orthomyxoviruses allows for increased antigenic shift
Antigenic Shift and Orthomyxoviruses
-Segmented genome allows for genomic shuffling/rearrangement
-Causes major changes in viral sub type
-Allows virus to change and jump from species to species
-Gives minor changes that change the virus and how a body interacts with the virus
Influenza A mutation frequency
-HIGH mutation frequency
-Single AA changes occur over time due to selective pressure and mistakes made by error-prone viral polymerase
-Cause antigenic drift
-Mutations occasionally make virus more pathogenic
-Minor changes that change virus and how abody interacts with the virus
Antigenic Shift
-Promotes fast evolution of viruses
-Gives virus means to jump from one species to another
-generates reassortment viruses
-Changes ability of the virus to interact with the host
-Can combine different strains to give new highly pathogenic strains with different viral proteins on the surface
Swine flu and antigenic shift
-Originated in March/April 2009 in Mexico
-Reassortment genome containing gene segments from avian, human, and swine influenza strains
-Transmitted to humans from pigs
--inhalation of viral particles
-Transmitted from human to human by inhaling viral particles
-Symptoms: high fever, coughing, sneezing, breathing difficulties, loss of appetite
Antigenic Drift
-Small mutations in key proteins
-Alter antigenicity and/or virulence
-Changes ability of virus ti infect, replicate, bud from the cells, etc.
Influenza virus binding
-Binds by HA protein
-Hemagglutinin
-Beinds sialic acid residues on cell surface
-Required for virus penetration and fusion
-HA mutations can directly affect pathogenesis
Hemagglutinin
-Surface protein on orthomyxoviruses/influenza viruses
-Allows virus to be infectious
-Binds sialic acid residues on the cell surface
-Mutations can directly affect pathogenesis
--can become much more efficient at binding
--can alter ability of virus to function
-Does not put the virus into the cell
--allows virus to attach
-HA0: non-infectious
-HA1 and HA2: infectious
Forms of Hemagglutinin
-HA0: non-infectious
--HA0 is cleaved by a host protein into HA1 and HA2
--Cleavage is required for viral penetration and fusion
-HA1 and HA2: infectious
--HA1: globular domain
--HA2: fusion peptide, linear form
-Allows virus to fuse with endosomal membrane
hemagglutinin Cleavage
-Cleaved from HA0 to HA1 and HA2
-Cleavage is required for viral penetration and fusion
-More cleavable HA leads to a more virulent virus
-Proteins have to change and become activated to fuse with endosomal membrane
-Cleavage exposes peptide and allows it to bind to the host membrane
-Host proteases cleave HA protein
Less Virulent Hemagglutinin
-Few basic residues at cleavage site
-Not cleaved easily
-No cleavage, no exposure, no fusion
-Only host proteases in the respiratory tract recognize and cleave protein
-Leads to respiratory tract infections
More virulent Hemagglutinin
-Many basic residues at cleavage site
-HA0 is cleaved easily
-Host proteases exist in many different cell types, can recognize and cleave HA protein
-Potentially deadly systemic infection
Influenza virus Fusion into Endosome
-Fusion is facilitated by cleavage of HA0 protein by host proteases
-Mediated by viral HA and M2 proteins
-M2 channel must be active for fusion
-Endosomal pH is key for viral fusion
Low pH and influenza virus Fusion
-low pH allows for activated M2 channel
-Ion enters the virion
-Viral protein interactions are altered
-HA conformational change occurs
-HA fusion peptide translocate 100Ao
-Fusion occurs and viral RNA segments are released into the cytoplasm
Influenza Virus Replication
-Replicates in the nucleus
-Assembly and packaging occurs in the cytoplasm
-Negative sense Viral RNA is transcribed into positive sense cRNA and mRNA
Influenza Virus Budding
-Due to Neuraminidase (NA)
-Temporary cleavage of Sialic acid, prevents HA from interacting with sialic acid
-Local disruption of Sialic Acid interaction with HA
Neuraminidase
-Component of influenza virus
-Allows virus to bud off of the host cell
-Cleaves Sialic acid from the cell surface, allowing release of infectious viruses
-Prevents HA from interacting with Sialic acid
-Local phenomenon near surface of the viral particle
Neuraminidase inhibitors
-Antivirals
-limit virus spread
-Reduce transmissibility
Drugs against influenza virus
-Symmetrel Fulmadine: M2 channel inhibitor
-Relenza Tamiflu: Neuraminidase inhibitor
Hemagglutinin and Neuraminidase subtypes
-16 hemagglutinin subtypes
-9 Neuraminidase subtypes

-Subtypes allow for different strains
Infection of animals by Influenza virus
1. Aerosol
-sneezing
-breathing
2. Fomites
-direct contact
-fecal matter

Enveloped virus, dies on dry surfaces
Influenza viruses infect many different species
-transfer between species via poultry, wild birds, and swine
Emergence of new Influenza Viruses
-Reassortment and mutations
-Modern pig and poultry production creates conditions for mass animal influenza outbreaks
-Proximity of humans and animals
--farms and markets
--creates potential for new viruses to emerge

Facilitates antigenic shift
HA and spread of influenza
-HA is a critical virulence factor
-HA restricts virus host range
--specific to host
-No prior immunity against new HA molecules
--new host is not protected, virus can go wild
NS1
-Internal protein of influenza virus
-Immune antagonist
--distracts the immune system and allows virus growth
Avian influenza virus
-Worldwide distribution
-Most important natural reservoir for influenza virus
--wild ducks, migratory birds
-Virus replicates in the lungs and cell lining the intestinal tract
-Fecal-oral transmission
-Tissue/organ specific proteases allows targeting of specific organs
-highly pathogenic avian strains H5 and H7 cause "Fowl Plague"
--systemic disease and CNS involvement
-Dx: virus isolation from cloacal swabs and serological typing or PCR
-Control with quarrantine, hygiene, and depopulation of infected flocks
Avian Influenza virus worldwide distribution
-Lots out bird flu in the world
-Lots of outbreaks
Avian Influenza Virus in PA
-May 1983, less than 10% mortality
-October 1983, more than 80% mortality
-Both were H5N2 strains
-2 key differences:
--Glycosylation site removed from HA from virulent strain, made one more virulent
--Multiple basic AA inserted at protease cleavage site
More cleavable HA
More virulent virus
Hong Kong outbreak of Avian Flu
-H5N1 virus transmitted directly to humans from birds
--Not human to human transmission
-New glycosylation site and additional basic AA present in H5 due to antigenic drift
-H5 HA is more readily cleaved by host proteases
--leads to systemic disease and high pathogenicity
Equine Influenza Virus
-2 subtypes
--A/Equine/Prague/1/56 (H7N7)
--A/Equine/Miami/1/63 (H3N8)
-Highly contagious via aerosol droplets
-Induces fever, dry cough, increased nasal exudate, secondary bacterial infections
-Infectious for at least 5 days
-3 weeks for complete recovery
-Vaccine is not effective, short-lived immunity only
-Control with quarantine, disinfection, and vaccination
-REPORT
Equine Influenza Virus Dx
-Virus isolation from nasopharyngeal swabs
-Influenza A antigen detection
-Paired serology
-PCR
Canine Influenza Virus
-Originates from Equine influenza virus
-First detected in racing greyhounds in 2004
--new dog-specific lineage H3N8
-2005: declared newly emerging pathogen in dog population in US
-Outbreaks in many states in 2013
-No evidence of transmission from dogs to humans
-Respiratory tract disease with secondary bacterial infections
--often mistaken for kennel cough
-Treatment is supportive
-1-5% mortality rate
-Vaccine exists
Pigs and Influenza Virus
-Pigs are "mixing vessels"
-Have cell surface receptors for both human and avian viruses
-Can support binding of viruses from many different species
-Over time, avian viruses in swine developed ability to recognize other receptors
Properties of Rhabdoviruses
-Enveloped
-Bullet shaped
-Have single external peplomer (G-protein)
-Helical nucleocapsid with linear negative-sense ssRNA genome
--11-15 kb
--encodes 5 structural proteins
-Replicates in cytoplasm
Structural Proteins encoded by Rhabdovirus genome
1. N: Nucleocapsid protein
2. P: Phosphoprotein (component of polymerase)
--interacts with L-protein
3. M: Matrix protein (assembly and budding)
4. G: Glycoprotein (attachment)
5. L: Large protein ( RN-dependent RNA polymerase)
--Interacts with P-protein

ONLY structural proteins encoded, no other proteins
Negri bodies
-Replicating rhabdoviruses in cytoplasm
-Focal areas of viral RNA
-Appear as red or dark bodies
-Diagnostic for rabies infection
-Replicating rhabdoviruses in cytoplasm
-Focal areas of viral RNA
-Appear as red or dark bodies
-Diagnostic for rabies infection
1. Vesicular Stomatitis Virus
-Vesiculovirus genus
2. Rabies virus
-Lyssavirus genus
Rabies Virus Tanscription and Replication
-Transcription occurs first
-Genome is organized so that most-needed protein is transcribed first
--allows for most about of protein to be made
--N-P-M-G-L
-mRNA transcripts are translated into viral proteins
-Replication gives +sense RNA, need replicative intermediate with +/- sense RNA to give –sense progeny RNA
Animal Rhabdoviruses
-Many different types
-Rabies is most important
--exists on all continents except Antarctica
Rabies incidence and distribution in USA
-Increasing since 19555!
-East coast: raccoon rabies
-Midwest: skunk rabies
-Texas: grey fox, coyote, dog rabies
-California: skunk rabies
-Canada and Alaska: Arctic Fox rabies
Oral Rabies Vaccine Project
-Recombinant Vaccinia virus expressing rabies virus G-glycoprotein
--live virus
-2ml of vaccine encased in wax layer with dog food or fish meal
-Vaccine is given in food, different recipes for different species
-Currently successful use in Texas and along east coast
Raboral
V-RG
-Oral Rabies Vaccine
-Cloned G-glycoprotein from rabies put onto vaccinia virus
-Dropped in various wildlife areas to provide vaccination to wildlife reservoir
Rabies vaccine bait
-Contains Raboral/V-RG vaccine
-Packet of liquid medicine within bait
-Tetracycline is also included
--animal inoculates self when biting into bait
--causes yellow markings on teeth, can identify animal as vaccinated
-NOT harmful to pets
Infectious path of Rabies Virus
1. Raccoon is bitten by rabid animal
2. Rabies virus enters raccoon through infected saliva
-virus may replicate a little in muscle tissue
3. Virus spreads through peripheral nerves to spinal cord and brain
4. Incubation in raccoon body for 3-12 weeks
-HIGHLY variable incubation period
-no signs of illness during incubation
5. virus replicates rapidly once it reaches the brain
-passes to salivary glands
-animal begins to show signs of disease
6. Infected animal dies within 10 days of showing signs
Rabies incidence in domestic animals
-Has dropped consistently since 1955
-Cats currently have highest incidence
-Conversely, cases in wild animals has increased since 1955
Rabies Pathogenesis
Zoonotic disease of wild and domestic animals
--can be transmitted to anyone and everyone!
-Entry via bite wound or skin abrasion
-Primary replication occurs locally in muscle tissue, low level replication
-Incubation period is highly variable
--usually 3-8 weeks, but can be more than a year
-Eventually infects peripheral nerves, travels to CNS and produces severe and fatal encephalitis
-Vaccine must be given EARLY for protection
-Dx: immunofluorescence of skin biopsies and presence of Negri bodies
Rabies Virus progression
1. Virus inoculated via saliva from bite or abrasion
2. Viral replication in muscle at site of wound
3. Virion enters PNS, ascends retrograde slowly, passive ascent via sensory fibers
4. Replication in dorsal ganglion
5. Rapid ascent towards spinal cord
6. Infection of the spinal cord, brainstem, cerebellum, ALL parts of brain are affected
7. Affects aggression areas of the brain, coincides with time when virus particles in saliva is high
8. Descending infection via nervous system to eye, salivary glands, skin, and other organs
Rabies virus in the Salivary Glands
-Formed by budding on the apical plasma membranes
-Virus is free to enter saliva
-Easily transmitted to the next host
Rabies Virus in the Brain
-Virus particles formed by budding on internal cellular membranes
-Virus is trapped
-Infects neighboring cells slowly
-Virus remains cell-associated
Location of Rabies Bite
-Determines incubation period
-Closer to the CNS, shorter incubation period
Clinical picture Classical/Furious of Rabies in Humans
-More common (80%)
-Prodronal phase
-Sensory excitation phase
-Coma and paralysis phase
Clinical picture of Dumb/Paralytic Rabies in Humans
-20% of cases, less common
-Prodromal symptoms, then directly to paralysis phase
-No sensory excitation phase
Prodromal Phase of Rabies infection
-Lasts 2-10 days
-Fever, headache, malaise, fatigue, anorexia
-Very general symptoms
Sensory Excitation Phase of Rabies Infection
-Lasts 2-7 days
-Neurologic symptoms develop
-Agitation
-Thrashing, convulsions, muscle spasms
-Virus has entered neurologic system
-not present in dumb/paralytic rabies
Coma and Paralysis phase of Rabies infection
-Mental status of patient deteriorates
-Sudden cardiac or respiratory arrest
-Coma
-All body systems deteriorate
Rabies Treatment Triad
1. Prompt, aggressive, first aid
-enveloped virus, easily inactivated
-tends to remain localized initially
2. Rabies vaccine for humans
-Killed vaccine, administered intramuscularly
-5 1.0 ml doses
3. Human rabies Immune Globulin
-Human hyperimmune serum is administered both systemically and locally
-Purified antibody, directed to G-protein
Dog and cat bite post-exposure Rabies prophylaxis
-Observe animal for 10 days
-No treatment for humans until animal develops signs of rabies
Bat bite post-exposure Rabies prophylaxis
-Regard as rabid
-Suspect exposure even if a bite wound is not clearly evident
-Unless proved negative by laboratory tests
Wild animal bite post-exposure Rabies prophylaxis
-Skunk, fox, coyote, raccoon, bobcat, woodchuck, other carnivores
-Regard as rabid unless proved negative by laboratory tests
Bat rabies
-700-800 cases of rabies in bats reported annually in US and Canada
-Most human cases of rabies in recent years have been bat-related
-Silver-haired bat by harbor highly virulent form of rabies virus
-Vampire bats feed on livestock
Case Study of Rabies in 4-year old girl
-Bat bites can be superficial and not easily noticed
-Bats behaving abnormally are always cause for concern
-Submit animal for rabies testing
-Consider bats to be rabid!
--low percentage are actually rabid, but better safe than sorry
Vesicular Stomatitis Virus
-Rhabdovirus
-Economically important disease in bovine and equine species
-2 serotypes in US and Canada
-Signs: excessive salivation, lameness, vesicular lesions on tongue, oral mucosa, and coronary band
--looks like FMD
-Outbreaks are often seen in western US in horses and cattle
-Enters animal through breaks in the skin or mucosa
--Lesions are NOT diagnostic
-May be transmitted by arthropods (sandflies)
-Zoonotic, gives influenxa-like illness in humans
Vesicular Stomatitis virion genome
-G
-P
-M
-N
-L
Rhabdoviruses in Fish
-Viral hemorrhagic septicemia virus (ebola virus of fish)
-Infectious hematopoietic necrosis viruses
Category A diseases/Agents
-High-priority agents
-Pose a risk to national security, potential bioterrorism agents
-Can be easily disseminated or transmitted from person to person
-Result in high mortality rates
-have potential to have major public health impact
-No specific treatment or vaccines
-Might cause public panic and social disruption
-Require special action for public health preparedness
Category A agents
-Anthrax (Bacillus anthracis)
-Botulism (Clostridium botulinum toxin)
-Plague (Yersinia pestis)
-Smallpox (variola major)
-Tularemia (Francisella tularensis)
-Viral hemorrhagic fevers
--ebola, marburg, arenaviruses
Hemorrhagic Fever Viruses
-Flaviviridae
--dengue, yellow fever, TBE group
-Arenaviridae
--lassa, junin, machupo, guanarito
-Filoviridae
--Ebola, marburg
-Bunyaviridae
--hantavirus
Ebola Virus
-Hemorrhagic Fever Virus
-First outbreak in 1976
-5 known strains
-EBOZ strain had highest mortality (88%)
-Ebola Reston is only in monkeys, not humans
-Last known strain in 2007
Key properties of Filoviruses
-Pleomorphic, have long filamentous forms and other shapes
-Uniform diameter of 80nm
-Vary greatly in length
-Composed of lipid envelope covered with peplomers surrounding helically wound nucleocapsid
-Single molecule of –sense ssRNA, 19.1kb
--largest of all –sense RNA viruses
-Infection is cytopathic in cultured cells and in target organs of host
-Cytoplasmic replication with large inclusion bodies
-Buds from the plasma membrane
Ebola virus Infection
1. Virus enters body via mucosal surfaces, skin abrasions, or parenteral introduction
2. Macrophages are infected, virus is amplified
3. Infection of macrophages can lead to immunosuppression in humans and non-human primates
-Cytokine storm disrupts cells
4. Dissemination via lymphatic and vascular systems
-endothelial cells are targets for replication
-Infection leads to vascular injury and increased permeability
--leads to hemorrhage and other circulatory dysfunctions
-Virus infects kidneys, adrenal glands, intestines, skin, and reproductive system
Ebola in the Respiratory system
-Alveolar macrophages are heavily affected
-Pulmonary endothelial cells are also affected
Ebola in the Spleen
-Deterioration of spleen functions
-Lymphoid cell depletion and generalized necrosis
Ebola in the Liver
-Liver functions eroded as hepatocytes, endothelial cells, monocytes, and kupffer cells are infected
-Large cytoplasmic inclusions can be detected in hepatocytes
Paramyxoviruses
-Important animal pathogens
-Canine Distemper Virus
-Newcastle disease Virus
-Bovine Respiratory Syncytial Virus
-Rinderpest virus
-Human Respiratory Syncytial Virus
-Parainfluenza virus
Properties of Paramyxoviruses
-Enveloped virus
-Has surface proteins
-150nm
-Negative sense single-stranded RNA genome
-1 genome segment that encodes all 7 genes
--No genetic reassortment, only 1 segment
Paramyxovirus proteins
-F: Fusion protein
-G: Attachment protein
-N: Nucleocapsid
-L: Large protein
-P: Phosphoprotein
-M: Matrix Protein
Types of Paramyxoviruses
-Respirovirus
-Rubulavirus
-Morbillivirus
-Pneumovirus

All have different proteins except for Fusion protein
Paramyxovirus attachment protein
-Hemagglutinin, glycoprotein, or hemagglutinin AND neuroaminidase
-Specific type depends on type of paramyxovirus
Paramyxovirus Replication Steps
1. Adsorption
2. Fusion with Sialic acid receptors on cell surface
-direct fusion, virus RNA is empties right into the cytoplasm
3. Uncoating
4. -Sense RNA is transcribed into mRNA and translated in cytoplasm
5. Antigenome is transcribed and replicated in the cytoplasm
6. -Sense genome fuses with plasma membrane and buds

Replication occurs in the Cytoplasm!
Key features of Paramyxoviruses
-Genome forms a ribonucleoprotein (RNP)
-Replication occurs exclusively in the Cytoplasm of the cell
-Envelope is derived from plasma membrane of the cell via budding
-Infection can result in:
1. Syncythia formation (giant cells)
2. Intracytoplasmic inclusion bodies
3. Intranuclear Inclusion Bodies
Syncytia
-Characteristic of Paramyxoviruses
-Cells fuse and form HUGE structures
Paramyxoviruses Inclusion bodies
-Inclusion body in astrocytic nucleus
-Accumulation of proteins
Paramyxovirus nucleocapsid
-Ribonucleoprotein
-Gives Herring-bone appearance to genome
-Well-protected RNA
Paramyxovirus vs. Orthomyxovirus
-Non-segmented genome vs. segmented genome
-Fuses with cytoplasmic membrane vs. fuses with endosome
-Replicates in cytoplasm vs. nucleus
-Endogenous capping vs. no endogenous capping
-Does not require a cellular primer for transcription vs. does require primer
-No genetic reassortment vs. lots of genetic reassortment
-Both need cleavage of surface glycoprotein
--paramyxovirus has own protease
-Both have single-stranded negative sense RNA helical nucleocapsid
-Sialic acid acts as receptor on cell surface (except in morbiliviruses)
-Both are enveloped
-
Paramyxovirus Adrosption and Fusion
1. HN or H or G binds to cellular receptor (sialic acid)
2. Binding causes conformational change in F-protein
3. F-protein is cleaved for activation
4. Viral and cellular membranes fuse when receptors engage
Properties of Paramyxovirus Adsorption and Fusion
-Basic AA at F-protein cleavage site increases virulence
-Alters ability of protease to cleave, promotes cleavage and leads to a more virulent virus
-Difference in a few AA can make a non-virulent strain into a virulent strain
Viral Transcriptase Proteins
-P and L proteins
-Allows for production of viral proteins from mRNA
-P and L proteins join with N protein for viral replication
--P,L,N forms viral replicase and generates viral genomes
Polarity of viral RNA transcription
-3' end has proteins that are needed in larger amounts
--end up undergoing more replication
-Gradient of proteins, and proteins accumulate in a gradient of concentration
-Always have more of the 1st protein
-Proteins are produced in the order they are needed for viral replication and assembly
-Replication can start with enough of 1st proteins have accumulated
Viral genomic replication
-Starts when enough NP protein has accumulated
-Transcriptase of PL becomes PLN and turns into replicase
Canine Distemper Virus
-Paramyxovirus, morbillivirus
-Polymorphic virus
-Important viral disease in canines
--80% mortality in unvaccinated animals
-Found in all fluids/secretions
-Spread via aerosol droplets
-Generalized infection with respiratory, intestinal, and urogenital tract complications
-CNS disorders, persistent infections, hard-pad disease on foot pads and nose
-Raccoon reservoir in PA
Canine Distemper Virus Treatment
-Vaccinate!
--formalin-inactivated and live-attenuated vaccines
-Exposed animals receive immune IgG
-Antibiotics can prevent secondary infections
-Expensive therapy and disease needs to be caught early
Newcastle Disease Virus
-Highly contagious
-Causes severe generalized infection in many avian species
--exotic pet birds, smuggled birds, etc.
-Transmission via airborne route, feed and water, transovarial infection
-Has caused many epidemics
-Results in big economic losses in poultry industry
-3 forms: lentigenic, mesogenic, and velogenic
-Cleavability of F-protein correlates to virulence
-Controlled through vaccination
Newcastle Disease Virus Disease forms
-Lentogenic
-Mesogenic
-Velogenic

-Different forms have different speed of disease
-Cleavability of F protein correlates with virulence
Newcastle Disease Virus Signs
-Depression and neurological signs
-Wing drooping
-Abnormal head and neck position
-Muscle tremors
-Legs dragging
-Paralysis
-Loss of appetite
Newcastle Disease Virus Treatment
-No specific treatment
-Live and killed vaccines are available
--administered in drinking water or by spray
Rinderpest Virus
-Acute, contagious disease
-Affects ruminants: cattle, buffalo, water buffalo
-"Bovine plague"
-Severe hemorrhagic inflammation of mucus membranes
-Severe gastroenteritis
-Severe stomatitis
-Greatest risk of spread is through transport of live animals
Rinderpest history
-Most important animal virus in history
-Reason for the start of veterinary medicine!
-Targeted for global eradication
--cell-culture adapted vaccines provide life-long immunity
-Declared eradicated in 2011
Morbilliviruses in Dolphins, Seals, Lions
-Dolphin Morbillivirus
-Porpoise Morbillivirus
-Phocine Distemper Virus
-Important pathogens, have caused a few outbreaks
-Clinical symptoms, RNA sequence, and antigenic profile mimic canine distemper virus
--also have inclusion bodies
Hendra Virus
-Emerging virus
-Natural reservoir in fruit bats
-Explosive outbreak of respiratory disease in Australia
--14 horses and 2 humans dead
-Causes severe interstitial pneumonia in horses
-Incubation period of 8-11 days in horses
-Causes acute febrile respiratory or neurologic illness
--results in death in 1-3 days
Hendra Virus outbreaks
-All in Australia
-39 outbreaks so far
-76 horses have died
-60% fatality in humans
-75% fatality in horses
Nipah Virus Spread
-Started in Ipoh in 1997
-Spread in Selangor as farmers sold pigs
-Human cases started in september 1998
Nipah Virus
-Causes encephalitis
-Natural reservoir in fruit bats
-Caused severe encephalitis outbreak in people with close contact exposure to pigs in malaysia and singapore
-265 cases and 105 deaths
--40% fatality
--10% relapse or late-onset encephalitis
Nipah Virus Infection of Pigs
-Predominantly a respiratory disease (upper respiratory tract)
--"barking pig disease"
-Low mortality with high infection rate
-Clinical signs are a mild to severe cough
-Occasional neurological signs
-Systemic endothelial cell tropism
-1.1 million pigs culled
-Transmission most likely from eating contaminated fruit
--close proximity of pig pens to mango trees
Nipah Virus and "Flying Foxes"
-Antibodies have been found in 5 malaysian species of bats
--4 fruit bats
--1 insectivorous bat
-Isolated in 2000 from bat urine
-Hendra Virus and Nipah Virus are closely related
--70-88% NT and 92% AA sequence identity
Borna Disease Virus
-Bornaviridae family of paramyxoviruses
-1st isolated in Germany
-Fatal, neurological disease of horses
--also affects sheep, cats, cattle
-Excitability, loss of coordination, abnormal positioning of the fore and hind legs, stands motionless with head down
-Causes bipolar disorder in humans?
-3-20 day disease course
-Virus enters intranasally, enters olfactory bulbs of the brain
Virus Goals
-Replication!!
-Dissemination, local or systemic
-Infection of more animals
Immune system goals
-Detection of pathogens
-Elimination and control of pathogens
-Prevention of tissue destruction
-Prevention of reinfection
-Cells:
--neutrophils
--eosinophils
--basophils
--lymphocytes
--monocytes
--platelets
--RBCs
Types of virus infections
1. Acute infection (influenza)
-High initial infection with resolution
2. Persistent infection (BVD)
-high initial infection that stays high, eventually leads to death
3. Latent infection (herpesviruses)
-repeated infections that may or may not produce signs
4. Lentivirus infection (SIV)
-virus is latent for LONG periods of time
Factors determining type of viral infection
-Strategies of the specific virus
-Viral adaptation to host species
-Immune response of the individual host
--Stress
--genetic factors
--co-infection
--environmental factors

Strategies of the virus
Adaptation to the host
Immune response of the host
Innate immunity overview
-Onset in 0-4 hours
-Response if by preformed, non-specific, or broadly specific effectors
-Effectors are able to remove the infectious agents
-Not hist-adapted
-Usually non-pathogenic
Early Induced Innate immune Response overview
-Response occurs in 4-96 hours
-Microbial-associated molecular patterns are recognized
-Inflammation and activation of effector cells by host immune system
-Infectious agent is removed
-No serum conversion, no adaptive immune response or clonal expansion
Adaptive Immune Response overview
-Late response, occurs after 96 hours of infection
-Antigen is transported into lymphoid organs and recognized by naive B and T cells
-Clonal expansion occurs and differentiation of naive cells to effector cells
-Antibodies are produced
-Infectious agent is removed
Inflammatory cytokines
-Induced by recognition of the virus
-Early response
Steps in Immune Response
1. Pathogen enters cell
2. Dendritic cells take up antigen and present on surface
3. Travel to lymph nodes and germinal centers via afferent lymph
4. Class switching occurs in germinal center
5. T cells and B-cells are activated, exit via efferent lymph
Time After Viral Infection
1-2 days: profuction of IFN-a, IFN-b, TNF-a, IL-12
2-4 days: NK-cell mediated killing of infected cells
6-9 days: T-cell mediated killing of infected cells
Host Innate Immune Response
-Invading virus triggers innate immune response (early response)
--NK cells arrive hours after infection
--Natural antibody occurs hours after infection (antibodies are already present)
--Complement activation hours after infection
--virus-induced interferon occurs a few hours to 4-5 days after infection
-Innate responses decrease viral load
-Innate responses eventually lead to stimulation of adaptive immune response
Alternative Complement Pathway
-Part of innate immune response
-Responds to viral particles and viral antigens (proteins)
-Antibody is not involved in the alternative pathway
-Complex sequence of events
-Opsonization leads to phagocytosis of virus
-Membrane attack complex lyses virus infected cells and enveloped viruses
-Activated complement contributes to inflammatory response
Opsonization of virus particles
-"Decorating" virus with C3b
-Makes virus more susceptible to phagocytosis
Virus inhibiting host complement factors
-Astrovirus and Influenza A virus inhibit C1
-Dengue virus inhibits C4b
-Vaccinia, variola, cowpox, HSV-1 and 2, and KHSV inhibit C3b
--do not allow complement pathway
-Prevent membrane from rupturing and cell dying
NK cells
-Recognize cells infected with the virus
-Help control the extent of the initial infection
-Receive activating signals from infected target cells
-Inhibitory receptor on KN cell interacts with loaded MHC-I on target cell
-Reduced/altered expression of MHC-I on virus-infected cells precents inhibitory signal, leads to lysis of infected target cells
-KN cells produce IFN-gamma
--leads to chemokine and adhesion molecule up-regulation
-Activated T-cells are recruited to tissue site
-Enhave the adaptive immune response
-BOTH MHC-I interaction and Activating receptor are needed to activate NK cell
Host detection of viral infection via Pattern recognition Receptors
-Pattern Recognition Receptors are on leukocytes and other cell types
-TLRs (Toll-like Receptors)
-RIG-I-like receptors
-RIG-I-like helicases
RNA virus detection via RIG-I-like receptors
-Major sensors of viral infection, depending on cell type
-MDA-5 recognizes Picornaviruses
-RIG-I recognizes paramyxoviruses, NDV, SeV, Rhabdoviruses, Flaviviruses, Orthomyxoviruses
RIG-I-like Receptors Viral Recognition
-Paramyxoviruses:
--Newcastle Disease Virus
-Sendai Virus
-Rhabdoviruses
--rabies
--vesicular stomatitis virus
-Flaviviruses
--hepatitis
-Orthomyxoviruses
--influenza
Virus PRR detection avoidance
-Produce gene products that interfere with TLR signaling
-Vaccinia virus protein A46R bloks signaling of TLRs and contributes to virulence
-HCV produces serine protease that degrades TRIF
-Interfere with TLR and RIG-I signals
Virus-induced interferon
-Interferons are host-specific, but not virus specific
-IFN-a and IFN-b are most common
-IFNs are produced at a high cost to the host
-Production is brief and transient
--hours to days post infection
-Made by infected cell
-Virus can still replicate in cell and kill cell
Type 2 interferons
-IFN-g produced by T-cells and NK cells
Type 1 interferons
-Interferon is produced by infected cells and plasmacytoid dendritic cells
-Produced by infected immune and non-immune cells
-Produced in large amounts by plasmacytoid dendritic cells
-Are produced by any affected cell
New Proteins in response to IFNa and IFNb
-IFN is release by first virus infected cell when it attaches to IFN receptor on 2nd uninfected cell
-Triggers cascade of events in 2nd cell
--2nd cell is IFN activated
--IFN response pathway
-More than 100 genes are affected
-Anti-viral state
Protection by Virus-induced interferon
-Induced cell: cell in anti-viral state is infected and host enzymes are activated
-Enzymes degrade host and viral nucleic acids
--Stops protein synthesis
-No new viral particles are made, no spread of virus to other cells
-Cell dies via apoptosis
Viral infection in Induced cell vs. uninduced cell
-both cells die
-In induced cell, no virus is produced and no virus is spread
--IFN is bound to cell
--no further infection
-In uninduced cell, virus replicates and spreads to other cells
--Infection is propagated
--no IFN bound to cell
Antiviral State Effector Proteins
-Produced by the cell
-Most interfere with viral entry, replication, and budding
-Some affect NK cell activation
--NK activated, target cell is lysed
-High cost for cell
Viral Anti-interferon strategies
-Viruses induce proteins that interfere with IFN action
-Block IFN receptors
-Interfere with IFN receptor signaling
-Produce proteins that allow virus to replicate, despite antiviral state
--inactivate antiviral state affectors
--ex: Influenza virus NS1 protein, allows for protein translation during antiviral state
-Virulence factors are important
Effects of IFN
-Up-regulation of antigen presentation by MHC-I
-Up-regulation of antigen presentation by MHC-II
--professional APCs
-"Shuts down" regional lymph node
--increased influx of lymphocytes and decreased exit
--Leads to increased antigen presentation
-Activation of NK cells
MHC-I of infected cells
-Virus-derived antigen is presented on MHC-I of infected cell
-Virus infects cell and viral proteins are synthesized in cytosol
-Peptide fragments of viral proteins are bound by MHC-I in ER
-Bound peptides are transported by MHC-I to the cell surface
-Viral fragments are displayed on the cell surface
-recognized by NK cells and CD8 T-cells
T-effector cell generation
-Cellular response of adaptive immune response
-APCs pick up antigen and migrate to draining lymph node
-Antigen is presented to naive CD8 T-cells (MHC-I) and CD4 T-cells (MHC-II)
-Causes T-cell proliferation and differentiaion
-During viral infection, cytokine environment typically induces IFN-g producing cells
--Th1 and CTLs
Effector T-cells during infection
-Go to site of infection
-CD8 positive CTLs recognize and kill infected targets
-CD4 positive Th1 cells produce IFN-g at site of infection
--activate macrophages and other phagocytes

T-cells are released and recruited for immune response
Cytotoxic T-cell Mediated Killing of Infected cells
-Cytotoxic T-cell recognizes viral peptide and MHC-I complex on infected cell
-Kills infected cell
Viral strategies to reduce antigen presentation
-Interfere with MHC-I loading
--inhibit antigen-processing and loading of MHC molecules
--Prevent transport of MHC to surface of the cell, degrade instead
-Block proteosome
-Block loading of MHC-I
-Block transport
-Degrade loaded MHC-I complex
-Divert MHC-I from surface to lysosome fro degradation
-DECREASE MHC-I ON CELL SURFACE
Effector B-cell generation
Humoral Immune Response
-Early B-cell response is mostly IgM
--leads to generation of germinal center reactions
-Germinal center reactions lead to high affinity IgG
-Mucosal responses lead to IgA production
Steps in B-cell activation
1. B-cell binds virus via viral coat protein
2. Virus particle is internalized and degraded
3. Peptides from internal proteins of the virus are presented to T-cell
--CD4 T-cell activates B-cell
4. Activated B-cell produces antibody against viral coat protein
--B-cell differentiates
Virus neutralization by Antibody
-Virus is coated and neutralized by antibodies
-Coated virus cannot enter other cells
-Antibody blocks binding of viral receptor and can also block a fusion event
Antibody-Dependent Cytotoxicity
1. Antibody binds to antigens on surface of target cells
2. Fc receptors on NK cells recognize antibody
3. Cross-linking of Fc receptors signals to NK cell to kill target cell
4. Target cell is killed, dies via apoptosis
Primary Antibody Response
-IgM is first antibody produced
--lasts 5-8 days
--has low affinity for antigen
--binds complement with high avidity due to multimeric character
-Class switching gives rise to IgG
--IgG lasts for longer but arises later (2-3 weeks)
--Has higher affinity for antigen
-Serum IgA goes up
-Secretory IgA is produced when virus infects via mucosa
Secondary Antibody Response
-IgM does the same thing it did during primary response
-IgG levels should appear sooner, increase more, and stay higher for longer than during primary response
--Higher affinity, more effective
Booster response
-Anamnestic response
-Memory repsonse
Immuopathology vs. Successful viral clearance
-Important balance of immune system!!
-Do not want to kill the body in the process of killing viruses
Mechanisms to limit immunopathology
-Produce anti-inflammatory cytokines
--IL-10
-regulatory cells
--Tregs, alternatively activated macrophages
-Viruses can induce immunosuppressive factors to reduce immune responses
--viral IL-10
Clever viral mechanisms
-Soluble Fc receptors that bind antibody
--decrease circulating antibody titers
-Produce chemokine binding receptors and molecules
--prevent recruitment of immune cells
-Produce chemokines that will recruit target cells for virus
--brings cells to infect to the virus
-Infects critical immune cells
--Ex: CD4 infection in HIV
Immunological memory
-MOST POTENT weapon against reinfection!
-Circulating antibody
-Antibody on body surfaces
-Circulating CD4 and CD8 T-cells, ready to respond to re-infection
-Shortcut response! respond within hours
Goals of Veterinary Vaccines
-Improve health and welfare for companion animals
-Be safe and promote health
-Increase production of livestock in a cost-effective manner
--cost-benefit resulting from vaccine is bottom-line
Prevent animal-human transmission from wildlife
When is a vaccine needed?
-When prevention is better than slaughter to control disease
--slaughter is not an option with humans, have to vaccinate
-When there are no drugs to treat or cure a disease
--most viral diseases!
-When virulence is due to toxin
--no time for antibiotic activity
Eradication and Vaccination
-Eradication is the goal, especially when there is an economic impact
-FMD, Rabies, Rinderpest
-Vaccination can lead to near extinction of viruses
--canine rabies in US
--Canine hepatitis virus in US
--Rinderpest
-Human vaccine successes:
--Polio, Measles, smallpox
Impact of Veterinary vaccines on Public Health
-Reduction in use of veterinary pharmaceuticals and hormones and residues in human food chain
-Use of antibiotics in animal production has been severely restricted
-Important impacts on human health through vaccination of animals
Salmon Disease Crisis in Chile
-Infectious Salmon Anemia (orthomyxovirus) is wreaking havoc on Atlantic Salmon
-Vaccine is available but ineffective
-Moving farms to pristine areas to reduce cycle of virus
--will also cause tons of environmental damage to pristine area
Veterinary vaccines vs. Human vaccines
-Less return on animal vaccines vs. human vaccines
--lower prices and smaller market size
--results in MUCH lower investment in R+D in animal vaccines
-Economic returns drive vaccine industry
-Veterinary vaccine development has less stringent regulatory and preclinical trial requirements
--also shorter time to market launch
--faster return on investment in R+D, but not as high of a return
Why to we vaccinate?
-To induce immunological memory without causing disease
-Adaptive immune response takes time to develop
--need primary infection
-Secondary infection takes MUCH less time for response
-Want to induce cellular (cytotoxic T-cells, IFN-g) and humoral (antibodies) immunity
Live vaccines
-Usually attenuated, not highly pathogenic
-Highly antigenic, cause big response
-Few inoculations needed
-Prolonged humoral and cellular immunity
-NO adjuvant is needed
-May have residual virulence reversion
-Can spread to unvaccinated animals
-Difficult to store
Killed/Protein vaccines
-Less immunogenic
-Need to be boosted
-Poor stimulator of cellular immunity
-Needs adjuvant to activate innate immune response
-Safer, will not spread to other animals
-Easy to store and manipulate
Veterinary live vaccines
-Live attenulated virus for vaccines
-Can use closely related virus from another host that will not cause disease
-Can package the virus in cell lines of chicken embryos
-Induce random mutations to make modified virus
-Select for a reduced virulence
Action of Veterinary live vaccines
-Induce mild infections and good cellular and humoral immunity
-Effective in small amounts, lead to biological amplification
-Long duration, can last a lifetime
-Do not require adjuvants
-Easy administration in drinking water, intranasal, or intraocular route
-Risky, can have residual virulence and reversion to pathogenic version
-Usually only need 1 shot, but use 2 to catch everything
-Wide range of herd immunity, big advantage
Live vaccines as a source of environmental contamination
-Porcine Respiratory and Reproductive Syndrome vaccine in Denmark
-European and American viruses are 55-80% identical
--cause distinguishable serological responses
--NOT the same virus
-Vaccinated pigs in Denmark with American strain
--caused reversion of virus and pigs had both types of viruses
-Virus reverted and became virulent
Smallpox Vaccine Success
-Live attenuated vaccine
-One host, only humans with NO wildlife reservoir
-No Asymptomatic shedding
--know if someone is sick and can contain
-Long incubation period
-Very obvious disease
-Very effective vaccine that is stable in the field
-Fear of illness enhanced cooperation
--worldwide compliance
-"Ring vaccination" plan, started at a focus and moved outwards
-Monitoring and reporting were critical
Rinderpest Vaccine
-Plowright vaccine
-Attenuated vaccine produced from Kabete O strain
--passaged 90 times in culture
-Lots of mutation with minimal reversion
-Safe, live viral vaccines are likely to require a number of attenuating mutations distributed throughout the genome
Rinderpest virus
-Morbillivirus
--related to measles and canine distemper virus
-Cattle plague
-Origin of veterinary medicine!
-Emerged from central/east asia and spread to Africa and Europe
-Domestic cattle are highly susceptible
--all domestic and wild ruminants are susceptible
--high morbidity and very high mortality
-Virulent and mild strains exist
Rinderpest Vaccine Success
-Short incubation and highly contagious virus
-Disease is easy to recognize
--Diarrhea, discharge, dehydration, death (and skin lesions)
-Fear enhanced worldwide cooperation
-High mortality led to famine
-huge effects on economies of many countries
-Ring vaccination used
-Effective vaccine produced in cell culture, stable in the field
-Rapid diagnostic tests for monitoring
-Well-developed plan for eradication
Veterinary Whole Inactivated or Killed Vaccines
-Viral inactivation achieved through heat or chemicals
--formaldehyde, thiomersal, ethylene oxide, beta-propriolactone
--proteins kill virus
-higher production costs and need for adjuvants
--makes vaccine more expensive to manufacture
--more inputs needed
Benefits to Veterinary Whole Inactivated or Killed Vaccines
-More stable than live vaccines
-Do not revert to virulence, no risk
-Can be used in pregnant animals
-Will give herd immunity of vaccine coverate is very high
Drawbacks to Veterinary Whole Inactivated or Killed Vaccines
-Unable to infect cells and activate cytotoxic T-cells
--less protective
--rely on antibody production
-Need strong adjuvants, large doses, and several injections to induce immunity
-Duration of immunity is not as long
--not a natural response, manipulated response
-Greater risk of autoimmune disease, allergic disorders, and vaccine injection site sarcomas
--STRONG inflammatory reactions!
Subunit Vaccines
-Isolated Protective viral antigens or recombination product
--target specific viral proteins
-Isolated antigens generally produce poor protective immunity
-Require repeated administration with strong adjuvants
-Ex:
--Porcilis PCV-2
--Classical Swine Fever virus vaccine
DIVA problem with Vaccines
-Differentiating Infected from Vaccinated Animals
-Existing vaccines cannot be used because they interfere with disease surveillance
-Serological testing will show antigens present, cannot tell if the infection is from the virus or the vaccine
-Can result in loss of "disease free" status in a country
-Differentiation is possible through genetic engineering of vaccines
--"Marker vaccines"
Marker Vaccines
-Allow Differentiation of Infected from Vaccinated Animals (DIVA)
-Can identify pathogen vs. vaccination
-Add "tags" to plasmid genome
-Used in Infectious Bovine Rhinotracheitis, Pseudorabies, Classical Swine Fever, FMD, WNV, etc.
-Need vaccine AND diagnostic test
Genetically Engineered Vaccines
-Reverse genetic approach used to construct chimera vaccine
-Take HA gene from one virus, combine with NA gene from another version
-Make virus with antigen and other markers
-Can use immunoassay to detect antibodies against N3 and N1 proteins
Live Viral Vector Vaccines
-Poxviruses used as vectors for exogenous genes
-Deliver vaccine antigens
-Have been used for human gene therapy
-Poxviruses can accomodate large amounts of foreign genes, can infect mammalian cells
--results in expression of large quantities of encoded proteins
-Ex: Rabies virus, FeLV,
DNA vaccines
-VERY SAFE vaccine
-Immunization of animals with naked DNA that encodes protective viral antigens
-particularly effective in fish
-Ex: Apex-IHN for Salmon
--protects Atlantic Salmon from infectious hematopoietic necrosis
--DNA vaccine encodes surface glycoprotein of IHN
--administered intramuscularly
Human Successful Vaccines
-Smallpox, Polio
-Measles, Mumps, Rubella
--autism debate
-Rotavirus, Hepatitis B
-Diphtheria, pertussis, tetanus
-Rabies
Animal Successful Vaccines
-Rinderpest
-Rabies
-Canine Hepatitis, Canine distemper
-Diseases controlled but not eradicated:
--FMD
Upper Respiratory tract
-Nose
-Nasal Cavity
-Pharynx
-Larynx
-Collection and delivery of air to the lungs
-Warming, filtering, and humidifying air
-Rhinitis, Pharyngitis, Laryngitis
Lower Respiratory Tract
-Trachea
-Bronchi
-Bronchioles
-Alveoli
-Distributes air throughout the lung
-Exchanges CO2 and O2 with the blood
--only occurs in alveoli
-Tracheitis, bronchitis, bronchiolitis, Pneumonia
Respiratory tract and Pathogens
-Most common portal of entry into the body
-Upper respiratory infections are mostly caused by viruses
--Normally not life-threatening
-Lower respiratory tract infections are mostly mixed infections
--often are life-threatening
--especially in susceptible individuals
Respiratory Tract Defense Mechanisms
1. Ciliated Epithelial Cells
2. Goblet cells
3. Innate immune components
Ciliated Epithelial Cells in Respiratry tract
-Beat in unison, wave-like fashion
-Propel mucus and entrapped foreign material towards oropharynx for removal or swallowing
Innate immune components fo Respiratory Tract
-Cells from innate immune system
-Pathogen recognition receptors
-Anti-microbial peptides
-Protect against infection and invasion
-Also trigger inflammation
Influenza Virus as a Respiratory Virus
-Different versions of the virus infect horses, dogs, cats, pigs, birds, ferrets, humans
-Has potential to jump through different animal species
-Lack of protective immunity in new hosts favors epidemics
-Swine act as a mixing area
Influenza Virus Pathogenesis
1. Virus is inhaled, binds to hair-like microvilli and cilia on surface of cells that line upper respiratory tract
-HA proteins attach virus to cell membrane
2. Virus grows in respiratory tract epithelium
3. Virus grows for 2-3 days without inducing inflammation
-incubation period
-After a few days inflammation is induced and symptoms become apparent
-MASSIVE infiltration of inflammatory cells
Consequences of Anti-viral immune response
-Onset of symptoms (know virus is invading the body
-Clearance of virus and infected cells
-Protection from future reinfection
-Will also have destruction of epithelial cells and loss of integrity of mucus layer
-Will be more susceptible to secondary infections
--immune system barrier is broken
Secondary infections in the lower respiratory tract
-Secondary infections are not a huge deal for upper respiratory tract, easily cleared
-BIG deal for lower respiratory tract
--have danger of complicated pneumonia due to secondary bacterial infections
-Non-pathogenic microflora has ability to invade and become pathogenic with viral infection
-Will have enhanced bacterial growth, inflammation, and lethality
Transmission of Respiratory Viruses
1. Inhalation of aerosolized virus
2. Direct contact with infected individuals
3. Contact with contaminated objects (fomites)

Close contact and over-crowding promote transmission
Increased humidity will decrease transmission
-droplets are too heavy, do not stay syuspended
Prevention of Respiratory Virus Transmission
-Isolation
-Vaccines
Feline Respiratory DIseases
-Still a problem even with widesread use of vaccines
-Most common in cats grouped together
-Open-mouthed breathing, weakness, severe coughing
-Feline calicivirus (RNA virus)
-Feline Herpesvirus-1 (dsDNA virus)
-Pasturella
-Chlamydophila felis
-Mycoplasma
Feline Calicivirus
-Non-enveloped, positive sense single-stranded RNA virus
-Major cause of upper respiratory tract disease in cats
-Predominant in colony cats
-Generally subclinical or mild infections
-Virulent strains lead to pneumonia in young kittens
-More virulent strains can spread systemically
--higher rate of mortality
-Some recovered cats remain persistently infected, may shed virus for months to years
Feline Calicivirus Diagnosis and Control
-Sings:
--nasal and eye discharge
--Ulcers on the oral mucosa
-Laboratory tests to distinguish from Feline herpesvirus 1
-Inactivated and modified live virus vaccines are available
--protects against clinical disease, does not prevent subclinical infection or carrier state
Feline herpesvirus 1
-Alpha herpesvirus
-Latent in the trigeminal ganglia
-50% of respiratory illness in household cats
-Low mortality with fair morbidity
-ranges from mild disease to serious
--most serious in kittens
-24-48 hour incubation period
-Secondary infections leading to pneumonia can occur
-once cat is infected, is infected for life
Feline Herpesvirus 1 Diagnosis and Control
-Signs:
--acute rhinitis
--fever
--conjunctivitis
-Inactivated or live attenuated vaccines are available
-Often combined with vaccines for feline parvo and calicivirus
Pasteurella multocida in cats
-Bacteria, gram- rods
-Commensal found on mucosa of nasopahrynx
-Host-adapted serotypes and biotypes
-Some serotypes are highly contagious primary pathogens
-Common secondary pathogen in cats
--stress related
-Causes rhinitis, otitis, bronchitis, pneumonia
Chlamydophila felis
-Intracellular bacteria
-gram- rods
-Causes feline pneumonitis
-Respiratory tract symptoms
-conjunctivitis, fever, conjunctivitis, nasal discharge, coughing, sneezing
-Contagious and widespread
-Not fatal, debilitated cats recover slowly
-Transmission via direct contact with infected secretions and droplet infection
-Control with attenuated live vaccine
--use restricted to cats at risk of exposure
Infectious tracheobronchitis
ITB
-Kennel Cough
-Viral and bacterial pathogens
-Group of pathogens
-Viral:
--canine adenovirus 2 (canine hepatitis virus)
--Canine herpesvirus 2
--Canine influenza
--Canine parainfluenza 2
-Bacteria:
--Bordetella bronchiseptica
--Streptococci, pasteurella, pseudomonas, mycoplasma
Kennel Cough
-Single-agent infections are generally mild and self-limiting
-Multiple agent infections are more serious and can result in pneumonia
--more common
-Clinical signs attributed to infection by 1 or many bacterial and/or viral agents
-HIGHLY contagious
-Dry, hacking cough, retching gagging
-Prevent via vaccination
Cacnine herpesviruses
-DNA viruses
-Latent in trigeminal ganglia
-Present in respiratory and gential tracts
-Closely related to FHV and PRV, but host-restricted
-Causes MAJOR viral infection in pups
--acute fatal generalized infection
--leading cause of death in puppies
-Can cause abortions or stillbirths
-Milder in adult dogs
-May be associated with Kennel Cough
-S: weakness, lethargy, crying, genital sores, death of newborn pups
-No vaccine available
Canine Adenovirus 2
-Double-stranded DNA virus
-Aerosol transmission
-Localized respiratory disease in canines
-Mild when alone
-Can be associated with Kennel Cough
-Can be more severe in combination with Bordatella, parainfluenza virus, canine herpes virus
-Looks like kennel cough
-Vaccination does not prevent infections, but will minimize symptoms
Canine Parainfluenza Virus
-Paramyxovirus
-Single-stranded RNA, negative sense genome
-Most common in dogs with infectious tracheobronchitis
-Infection typically in upper respiratory tract
--allows secondary infection by other agents
-Can shed for about 1 week
-Will have nasal discharge and dry unproductive cough
-Vaccine is available and routine in puppies
Bordetella Bronchiseptica
-Gram- bacteria
-Obligate aerobe
-Most common agent isolated from dogs
-Preferentially attaches to and replicates on cilia of respiratory epithelium
-Synthesizes potent toxins that impair phagocytic function, induce ciliostasis
-Facilitates infection from opportunistic agents
-Looks like kennel cough
-Prevent secondary infection with antibiotics
Respiratory Diseases of Bovines
-AKA shipping fever
-Mix of viruses and bacteria
-Viruses:
--bovine herpesvirus 1
--bovine parainfluenza
--Bovine viral diarrhea virus
--Bovine respiratory syncytial virus
--Bovine corona virus, adenovirus, and rhinovirus
-Bacteria:
--pasteurella hemolytica
--Pasturella multocida
--Haemophilus somnus
--Mycoplasma
--Chlamydia

Not all are present in any one outbreak
Bovine Respiratory Disease
-Most common disease of feedlot cattle
-Most costly disease of cattle
--$1 billion per year in losses
--$3 billion spent on preventatives and treatment
-Pneumonia accounts for a lot of mortality in dairy calves (24%)
-Combination of respiratory pathogens and compromised innate immune system predisposes animals to BRD
Porcine Respiratory Diseases
Bacterial
-Pasturella multocida: bronchopneumonia
-Pasturella multocida and Bordetella bronchiseptica: Atrophic rhinitis
-Actinobacillus pleuropneumoniae
--hemorrhagic necrotiing pneumonia
--Severe and contagious disease in pigs less than 6 months
Porcine Respiratory Diseases
Viral
-Porcine Herpesvirus 2: alpha herpesvirus
--rhinitis in young pigs up to 10 weeks old
-Swine Influenza: orthomyxovirus
--single stranded segmented RNA virus
-Porcine reproductive and respiratory syndrome virus
--most important swine disease in the US
--high economic impact
Porcine Reproductive and Respiratory Syndrome Virus
PRRS
-Arterivirus
-Enveloped +sense single stranded non-segmented RNA virus
-Pandemic disease that causes abortion and pre-weaning mortality
-Highly transmissible
-Pose-weaning respiratory syndrome
-Shed in urine, saliva, semen, feces
-85-95% of pigs in herds are seropositive within 2-3 months
-Long duration of infection and shedding in clinically sound carriers
-Vaccines for some strains are available
Viral Respiratory Diseases of Birds
-Avian Influenza Virus
-Fowl Pox
-Avain Coronavirus
-herpes virus: layingotracheitis
-Newcastle disease virus
Bacterial respiratory diseases of Birds
-Klensiella
-Proteus
-Chlamydophila
-Pasturella
-Avian tuberculosis
-Mycoplasma gallisepticum
Fungal Respiratory Diseases of birds
-Fungal pneumonias
-Aspergillosis
Integumentary system
-Largest organ in the body, 12-24% of animal body weight
-70% water
-Skin, hair, nails, sweat and oil glands
-Main function is protection from bacteria, chemicals, temperature, dessication
-secretions can kill bacteria
Skin Structure
-2/3 layers
-Epidermis, dermis, subcutis/hypodermis/superficial fascia
Epidermis
-Multiple layers of cells
-Keratinocytes, melanocytes, langerhan's cells, Merkel cells
-Cells are produced from columnar basal cells are are attached to the basement membrane
-Rate of mitosis and keratinization is controlled by nutrition, hormones, tissue factors, immune cells in the skin, genetics
Stratum Corneum
-Compact layer of dead cells
-Impermeable barrier to loss of fluids, electrolytes, minerals, nutrients, and water
-Prevents penetration of infectious/noxious agents into skin
-Lipid content and keratin arrangement is critical for barrier function
-Continuously desquaminated/shed
Melanocytes
-Lovated in the basal cell layer
-Responsible for pigment production
-Under hormonal and genetic control
Langerhan's cells
-Mononuclear dendritic cells
-involved in regulating the immune system of the skin
-Damaged by excessive UV light exposure and glucocorticoids
-Process antigenic and allergenic material
Merkel Cells
-Specialized sensory cells
-Associated with skin sensory organs
--whiskers, pads
Skin defenses
-Not a favorable environment for microbial growth
-Dry
-Desquamination occurs, constant shedding allows body to get rid of transient bacteria
-Secretions and excretions
-Microbial interactions
-Immune system
-Keep bugs away that should not be there
Microbial Flora
-Important role in defense
-Normal skin flora
-Gram+ organisms mostly, yeast is also common
--staph, strep, corynebacterium, proprionibacterium, micrococci
-Transient flora: b-strep, E. coli, P. mirabilis, enterococci
-Normal flora is commonly the source of skin infections
-VERY complex system, provides protection and infection
Dermatitis
-Inflammation of the skin
-Can be produced by external irritants, burns, allergens, trauma, infection
-can be associated with concurrent internal or systemic disease
-Hereditary factors can also be involved
Pruritus, scaling, erythema, thickening or lichenification of the skin, hyperpigmentation, oily seborrhea, odor, hair loss
-Breaks in the skin allow for normal flora to become pathogenic
Canine Pyoderma
-Pus on the skin
-Any condition that results in the accumulation of neutrophilic exudate
-More common in dogs, less common in cats
-Microorganisms cause inflammation, which leads to pus
-Caused by infectious, inflammatory, neoplastic etiologies
-Classified by depth of infection, etiology, and primary or secondary
-Usually superficial, especially bacterial pyoderma
-
Interdigital Furunculosis
-Deep pyoderma
-Painful nodular lesions in the interdigital webs of dogs
-Histologically lesions represent areas of nodular pyogranulomatous inflammation
--may or may not see microorganisms
-Often get secondary bacterial infections due to licking
-Staphylococcus pseudointermedius is most common agent
Bites and Wounds
-Deep into skin, into dermis
-Blood supply can remove organisms
-Pasteurella multocida is most common
--present in the mouths of cats
--short gram- rods/coccobacilli
--stinky odor
Post-operative wound infection
-Primary MRSA infection
-Probably physician induced or from hospital
-Cause deep skin and soft tissue infections
Bacterial Agent of Skin infections
-Staphylococcus (all species)
-Actinomyces (dogs, cows)
-Pasteurella multocida (cats)
-Mycobacterium (cats)
-Dermatophilus congolensis (horses, sheep)
-Erysipelothrix rhusiopathiae (pigs)
-Arcanobacterium pyrogenes (cows)
-Dichelobacter nodosus (sheep)
Fungal Agents of Skin Infections
-Microsporum canis
-Malassezia
Dermatophytosis
-Infection of the keratinized tissue
--skin, hair, claws
-Can be due to:
--Epidermophyton
--Microsporum
--Trichophytom
Cutaneous lobomycosis
-Caused by yeast-like organism
-Affects skin and subcutaneous tissues
-Human pathogen
--transmitted from humans to dolphins or from dolphins to humans?
-Due to immunosuppression?
Chytridiomycosis
-infectious disease affecting amphibians
-Caused by chytrid fungus
--Batrachochytrium dendrobatidis
-Can cause sporadic deaths in some amphibian populations
-Major cause of amphibian die-offs?
-Origin and impact on populations is still unclear
Avian Pox
-Slow-spreading viral disease in birds
-Wart-like nodules on the skin
-Diphtheritic necrotic membranes lining the mouth and upper respiratory system
-Present in birds since forever
-Transmitted via direct or indirect contact
-No treatment
Pox diseases
-Acute viral diseases
-Affect many animals
--humans, birds
--not dogs
-Lesions of skin and mucosa
-Widespread, progress from macules to papules, vesicles, and pustules
-Infection via inhalation or through skin
Musculoskeletal System
-Bones, cartilage, muscles, ligaments, tendons
-Structural framework for body
-protects vital organs
-Provides capacity for locomotion
Infections of the Musculoskeletal system
-Initiated by introduction of microbes
-Direct inoculation from traumatic or iatrogenic events
--bites, trauma, catastrophic events
-Extension of infectious processes from contagious foci
--infection can be from somewhere else
-Hematogenous seeding from distally infected sites or septicemia
--blood brings infection to area
Osteomyelitis
-Infection of the bone
-Can be acute or chronic
-Lameness, pain, abscesses at the wound site, fever, anorexia, depression
-Radiographs will show bone changes
-Deep fine-needle aspirates, cytology, and blood cultures revela evidence of infection
-Bone changes at site indicate infection
Septic Arthritis
-Inflammation in a joint
-Can result in changes to joint cartilage, joint fluid, bones, or joint capsule
-Can be immune-mediated, infective, idiopathic
-Infective arthritis comes from bacterial infection in a joint
--hematogenous infection
--traumatic injury
--iatrogenic infection from joint injection or surgery
Immune-mediated Arthritis
-Inflammatory polyarthritis
-Secondary to deposition of immune complexes
-Can be erosive or non-erosive
Lyme disease
Can manifest in MANY ways
-Limb and joint disease
-Neurologic, cardiac, renal abnormalities
-Lymphadenopathy
Common bacterial agents in Musculoskeletal Infections
-Actinomyces
-Actinobacillus
-Arcanobacterium
-Fusobacterium necrophorum
-Beta-streptococcus
-Borrelia burgdorferi
-Brucella canis
-Chlamydophila
-Clostridium
-E. coli
-Erysipelothrix
-Leptospira
-Mycoplasma
-Pasteurella
-Salmonella
-Staphylococcus
Fungal agents causing musculoskeletal infections
-Aspergillus
-Blastomyces
-Coccidioides
-Subcutaneous mycoses
Myositis
-Infection of muscle
-Localized abscess, granuloma, or diffuse inflammatory process in muscle
-Can be due to trauma, injections, bite wounds, contagious infectious process, subcutaneous abscess, osteomyelitis
-Granulomatous myositis caused by Mycobacterium, Actinomyces, or Actinobacillu
Necrotizing Myositis
Blackleg
-Caused by Clostridium chauvoei
-Acute, febrile disease of cattle and sheep
-Causes swelling in the muscles
-Can prevent with vaccination
Mycobacterium bovis
-Granulomatous disease of muscle
-Usually chronic, but can also have an acute rapidly progressive form
-Affects all vertebrates
Septicemia
-Presence of pathogenic organisms in the blood stream leading to sepsis
-Bacterial sepsis and septic shock
-Characterized by vascular collapse and multi-organ failure
-Most commonly gram- bacteria
--Enterobacteriaceae
-Pseudomonas aeruginosa and Staphylococcus can also cause sepsis and speticc shock
-Loss of control of cases lets organism get into the bloodstream
Septic Shock
-Caused by LPS virulence factor in gram- organisms
--binds to receptor signaling complexes on monocytes and macrophages
-Causes dysregulation of the immune response
-Production of excessive levels of proinflammatory cytokines
-Cytokines are responsible for the systemic effects
--cytokine storm
Function of the Digestive System
-Process food
-Provide nutrition of the body
-Complex physical, secretory, and absorptive processes
-Represents an open tube to the environment
-Opportunity for exposure to pathogens
Anatomy of the Digestive System
-Varies between animals
-Carnivores: oral cavity, esophagus, stomach, small and large intestines
-Herbivores: more fermentation
--ruminant digestion
--cecal digestion
-Poultry: specialization with crop, glandular stomach, and muscular stomach
Properties of the Digestive System
-Anatomic, physiologic, and immunologic mechanisms protect from pathogens
-Acid production in the stomach provides a major barrier to infection
--inactivates viruses and kills most enteric bacteria
Peristalsis
-Moves digesta caudally
-Major role in host defense in small intestine
-Regulates microbial population in the small intestine
-Maintains distribution and number of normal gut flora
Mucus and mucosal integrity in the GI system
-Important barrier to infection of the digestive system
-Prevents systemic infection
-Mucus binds to microbes, blocks interaction with epithelial cells
-Normal flora is a powerful defense
--produces, maintains, and regulates the mucus layer
-C. difficile will destroy the mucus layer and allow other microbes to invade
Microbial Flora
-Complex ecosystem inhabits digestive tract
-normal flora protects against pathogens
-Plays an important role in physiological health of the host
-Promotes functional villi formation
-Synthesizes nutrients
-Contributes to the establishment of a functional mucus consistency
Establishment of GI microbial flora
-Normal microbial flora is established soon after birth
-Organisms are acquired from mother and environment
-Flora establish a niche using bacterial and host properties
--bacteriocins and microcins
--production of fatty acids by obligate anaerobes
-Proportions may change over time but microorganisms do not
Disruption of GI microbial flora
-Antibiotics
-Disrupt susceptible oral flora, leads to population with resistant Enterobacteriaceae and environmental organisms
--enterbacteriaceae moves in
-Results in dramatic shift in population
-Obligate anaerobic communities in mouth and large bowel are affected
--leads to overgrowth of resistant enterobacteriaceae due to decreased fatty acid levels
--removal of long-chain fatty acids that keep microbes in check
Oral Flora composition
-Obligate anaerobes make up most of the normal oral flora
--every individual is different
-Streptococci
-Enterobacteriaceae
-Pateurella
-Actinomyces
-Neisseria
-Simonsiella
-Gingival crevice is entirely obligate anaerobes
--bacteriodes
--fusobacterium
--peptostreptococcus
--Porphyromonas
--Prevotella
Rumen Flora Composition
-Complex microbial community
-Bacteria, fungi, and protozoa
-In delicate balance with host to maintain proper fermentation in rumen
-Most are obligate anaerobes
--bacteria specifically designed for digestion of cellulose-rich forage
Infections of the digestive system
-Important in all domestic animals
-Some pathogens are host-specific, others can affect many different animal species
-Need to maintain non-specific resistance and specific immunity
Infections of the Oral Cavity
-Susceptible to infection by various endogenous and exogenous microbes
--endogenous= bacterial and fungal
--exogenous= viral
-Mostly due to anaerobes
Infections of the Esophagus
-Uncommon due to rapid transit time
-Stratified squamous epithelium lines esophagus, relatively impenetrable
Infections of the stomach, ruminant forestomach, and abomasum
-Stomach is not a hospitable environment for pathogens
--high acidity and mechanical breakdown of material
--Contractile nature causes relatively rapid transit of ingested material
-Damage to mucosal surface of rumen/reticulum or disruption in rumen flora can lead to serous and potentially fatal cosequences
-Sudden dietary changes lead to a pH reduction
--kills acid-sensitive rumen flora
--damages rumen mucosa
-Disruptions do not need to be infectious, but allow for infection
Infections of the small and large intestine
-Affect all domestic animals
-Clinically and economically important in horses, production animals, and poultry
-Result in vomiting and diarrhea
-Severity, duration, and characteristics of diarrhea differ based on infectious agent and host species
Salmonella pathogenesis in the digestive tract
-Major food-borne pathogen
-Persists in intestinal epithelium and lymph nodes for 3-6 weeks
--intermittent shedding
-Shedding can reactivate during periods of stress
-All 25 salmonella serovars can be pathogenic
-Need to ingest a large number of organisms to produce GI colonization
-If organisms survive passage through the stomach they can colonize middle portions of the ileum
-Attach preferentially to the tips of villi, invade, multiply
Salmonella Virulence Factors
-Exotoxins
-Adhesion pilli
-Capsule
-Adhesins
-Virulent enzyme
-Flagella
-LPS
-Fe binding protein
Salmonella Gastroenteritis
-Variable clinical signs
--vomiting, diarrhea, sometimes both
-Acute episodes occur 3-5 days after exposure, minimum of 12 hours after exposure
--usually acute condition, not chronic
-Fever, malaise, anorexia, vomiting, abdominal pain, diarrhea
-Cats frequently hypersalivate due to vomiting
-Diarrhea will be watery, mucoid, and bloody if severe
--watery due to dilution with fluids from the body
--mucoid due to erosions of the gastric layer
-Pale mucus membranes, weakness, dehydration
-Cardiovascular collapse, shock, icterus before death
-Pneumonia can also be associated with acute disease
CNS signs of Salmonella gastroenteritis
-Hyperexcitability
-Incoordination
-Posterior paresis
-Blindness
-Convulsions
Salmonella lab diagnosis
-Culture is the gold standard
-PCR first, and if positive confirm with culture
-Presence of organism may not indicate clinical disease
-Negative culture should not eliminate possibility of infection
Salmonella prevalence in dogs and cats
-Low prevalence
--reported in 1-4% of dogs, 0.3-8% in cats
-1.3-30.9 million pets potentially infected in US
Salmonella Treatment
-Varies with extent of disease
-Fluid replacement
-Antibiotic therapy is NOT indicated
-Drug Tx induces resistant strains, prolongs convalescent shedding
-Amoxicilin, chloramphenicol, 3rd generation cephalosporins
-Severe systemic cases may require plasma transfusion
Antibiotic therapy is NOT indicated for treatment of uncomplicated Gastroenteritis
Salmonella
Campylobacter
-Gram- motile bacterium with polar flagellum
-Mostly infection of companion animals
-Caused by campylobacter jejuni or C. coli
-Diarrhea
-Zoonotic, animals can serve as source for human infection
-Common contamination of poultry meat
Campylobacter pathogenesis
-Severity depends on number of organisms ingested
-2-10 day incubation period
-Invades epithelium of small intestine and causes inflammation
--inflammation leads to disease progression
-Virulence factors have been identified in C. jejuni
-Stress may increase the severity of disease
Campylobacter virulence factors
-Is a PATHOGEN!
-Enterotoxins
-Cytotoxins antigenically similar to cholera toxin
-Adherence factors
-Invasion of intestinal epithelial cells causes congestion, edema, mucosal ulcers and occasional sepsis
Campylobacter clinical signs
-Same presentation as salmonella (diarrhea, vomiting)
-May have asymptomatic carriers
-Mostly affects young dogs, less than 6 months
-Diarrhea will be mildly loose, water, mucoid, bloody feces
-Acute diseases will present with water, mucus, or bile-streaked diarrhea
--May or may not have blood and leukocytes
-5-15 day duration of disease
-Diarrhea can be chronic, intermittent, or last for several months
-Has a lower infectious and zoonotic dose than salmonella
-Can do a fecal smear to ID
Campylobacter in Cats
-Clinical signs are poorly documented
-Infection can be asymptomatic
-Can be observed with other organisms
--giardia, toxocara
-Animals less than 6 months old show signs
--depression, anorexia, diarrhea
Campylobacter prevalence in dogs
-1-34% infection in healthy adult dogs
-up to 53% infection in adult dogs with diarrhea
-5-39% prevalence in normal puppies
-75% prevalence in puppies with diarrhea
-Conflicting reports on prevalence
Campylobacter lab diagnosis
-Microscopy
--Spirals indicate campylobacter
-Viable at room temp for 3 days in feces
-Culture in O2 reduced atmosphere
-Oxidase+ and catalase+
-Susceptible to nalidixic acid
-Resistant to cephalothin
Campylobacter treatment
-Efficacy of antibiotic therapy is not known
--not thought to effectively alter the course of disease in dogs and cats
-Therapy may be needed in severe cases
-Erythromycin is the drug of choice (Baytril)
-Fluoroquinolones are over-used, campylobacter is resistant
Icosahedral RNA viruses
-Enveloped viruses
-Non-enveloped viruses
Helical RNA viruses
-All are enveloped viruses
-Rhabdoviridae
-Paramyxoviridae
-Orthomyxoviridae
-Coronaviridae
-Retroviridae
Positive sense RNA genome viruses
-RNA is the same sense as the mRNA
-RNA is considered to be infectious
-Initial event is translation by host ribosomes
-Synthesizes a -sense Intermediate RNA as part of replicaiton scheme
Negative sense RNA genome viruses
-RNA is not in the same sense as the mRNA
-Initial event is transcription
-RNA is NOT infectious
-Synthesizes a +sense intermediate RNA
-Need a viral polymerase, virus bring polymerase with it
-Has an extra step in viral production and replication
Picornavirus properties
-Small RNA viruses
-Large family of human and animal pathogens
-Icosahedral capsids
-Non-enveloped
-Apthovirus genus
--Foot and Mouth
Picornavirus genome
-Linear
-+sense
-Single-stranded RNA
-Single piece of +sense RNA with a poly A tail
-VPg at the 3' end acts as a capping protein
-Translated into a polyprotein
--one large reading frame
--Cleaved at the same time that it is transcribed
--Proteins are grouped according to function
Aphthoviruses
-causative agent for foot and Mouth disease
-7 serotypes
--A, O, C, SAT1, SAT2, SAT3, Asia
-Still significant veterinary pathogen
-Not in US, but could cause MAJOR epidemic
--could be a major bioterrorism agent
Foot and Mouth Disease
-Tiny circular/smooth particles
-Endemic in a number of countries
--S. America, Europe, Africa, Asia
-North America is Virus-free
--Last outbreak in 1929 in Chicago area
-High restrictions on imports and exports
-Vaccination is not "virus free"
Pathogenesis of Foot and Mouth
-Highly contagious
-Most feared disease of cattle worldwide
-Transmission via aerosol inhalation and contaminated food
-Easily spread
-Non-envloped virus, very stable in the environment
-Replicates in the pharynx, causes primary viremia within 24 hours
--secondary virema allows virus to spread to other target organs
-High fever within 48 hours
-Will have vesicles on the skin of the animal
-Signs: excessive salivation, slobbering
--vesicles prominent on the oral mucosa/tongue
--vesicles on the coronary bands around the feet
-Animals have difficulty moving, walking, eating, drinking
-Loss of condition in animals
-Secondary bacterial infections are common
-Hard to differentiate from other viruses
FMD look-alike viruses
-Swine vesicular disease (Enterovirus)
-Vesicular stomatitis (Rhabdovirus)
-Vesicular Exanthema of Swine (Clicivirus)

Animal with ulcers on skin or oral mucosa cannot be assumed to have FMDV before additional testin
-Can start diagnosis based on which animals get which diseases
Diagnosis of FMDV infection
-Rapid diagnosis is most important
--need to start quarantine and eradication procedures
-Collect specimens from vesicular fluid
--on epithelial tissue near edge or ruptured vesicles
-Samples should be frozen immediately if possible
-Maintain samples in neutral pH with buffer
--Acidic conditions will inactivate the virus
-Diagnostic tests exist, ELISA assay is most used
Swine vesicular disease vs FMDV
-Cannot tell the difference between viruses based on vesicles!
Why is FMDV so feared?
-Where virus has been eliminated, virgin soil epidemic could develop rapidly
--there is no immunity to the virus
-Virus is efficient at shutting down the host cell
--can produce up to 1 million virions per infected cell within hours of infection
--Uses host cell proteins and functions to make viral proteins
-Large amounts of highly contagious virus can be excreted from infected animals before onset of clinical signs
--can excrete virus up to 24 hours before clinical signs
-Long distance spread of FMDV can occur
--carried on wind currents!
-Virus can survive frozen, cured, and partially cooked meat
2001 outbreak of FMDV in UK
-Origin of outbreak traced to virus-containing swill that was fed to pigs
-4,047,000 animals were slaughtered
-more than 10,000 farms affected
-First clinical signs observed in feb 2001, took a year to get rid of
-Type O panAsia strain
-No vaccination used to control, just slaughter
--Devastating!
Problems with vaccinating for FMDV
-Current commercial vaccines would interfere with serological monitoring
--DIVA issue
-Current killed vaccines may be contaminated with live virus
-Immunity is strain-specific, would not be able to protect against all strains of the virus
-Immunity is not life-long
-Carrier states exist
Future of vaccinations for FMDV
-Development of marker vaccines
--protective, lack 1 or 2 specific viral proteins
--can distinguish vaccination vs. infection in animals
-Development of diagnositc kits
Humans and FMDV infection
-Humans can be infected
-Infections are usually mild or sub-clinical
-Humans can act as carriers of the virus
--humans, clothing, boots, tires, anything!
--Contribute to the spread
Coxsackie A virus
-Hand, foot, mouth disease virus
-Similar to foot and mouth virus
-only in humans
Calicivirus structure
-Cup-like shapes on surface
-Icosahedral protein shell
-Non-enveloped virus
Caliciviruses of Veterinary Importance
1. Vesicular exanthema of swine
2. San Miguel sea lion virus
3. Canine calicivirus
4. Feline calicivirus
Vesicular Exanthema of Swine
-Calicivirus
-Foot and Mouth disease look-alike, causes very similar lesions
-Mostly in pigs
-Originated from San Miguel sea lion virus
--Feeding contaminated sea lion and seal meat to pigs?
--RNA virus, is able to mutate genome frequently
-Causes cutaneous vesicular disease
RNA viruses and mutations
-No proof-reading capability in genome
-RNA polymerase will make mistakes in replication and mistakes will not be repaired
--passed on
-High mutation frequency
Canine calicivirus
-Dog host
-Usually a mild diarrhea disease
-On own not too big of a deal
Feline Calicivirus
-MAJOR upper respiratory tract infection in cats
-Affects wild and domestic cats
-40-50% of upper respiratory tract disease
--rhinitis, vesiculation, ulceration of the oral epithelium
-Number of different strains, range from mild to very virulent
-Virulent strains appear through mutations
--causes significant disease in cats
--vasculitis, systemic disease
-A percentage of cats remain persistently infected, can shed virus for months to years
-Persistent infection!
Diagnosis and control of feline Calicivirus
-Upper respiratory tract signs (suggestive)
-Ulcers on oral mucosa (suggestive)
-Laboratory tests must bee used to distinguish from Feline Herpesvirus 1
-Make Dx based on rising antibody titer in paired serum sample
-Vaccines exist
--killed and modified live vaccines
--protect against clinical disease but do not prevent against subclinical infection or carrier state
Astroviridae
Astrovirus
-Non-enveloped virions with star-like appearance
-Linear, +sense single-stranded RNA genome
-Infect a wide-range of domestic animals
-Cause mild gastroenteritis
-Serious disease occurs rarely, in ducks
-Transmitted via fecal-oral route
--possibly via contaminated feed and water
-No vaccine exists due to mild nature
Flaviviruses
-"Yellow"
-Flavivirus: Yellow fever, Dengue, west nile
--arthropod-borne viruses
-Pestivirus: BVDV
--non-arthropod-borne viruses
-Spherical, Enveloped virions
-Icosahedral symmetry
-Linear, +sense single-stranded RNA
-Cytoplasmic replication
-Express proteins as a poly-protein
Bovine Viral Diarrhea Virus
BVDV
-Pestivirus
-Transmitted via contact, congenital
-Occurs in cattle and calves
-Mostly an inapparent disease
-Can be congenital disease
-persistent infection
-Mucosal infection is severe, causes infection
-Occurs world-wide
BVDV mucosal disease
-Severe form of disease
-Can only occur in persistently infected animals
Polyprotein
-Long protein chain transcribed from viral RNA
--one long open reading frame
-Structural proteins are usually at 5' end
-Non-structural proteins are usually at 3' end
-Cleavage occurs from viral proteins
Bovine Viral Diarrhea Virus
BVDV
-Common in cattle populations worldwide
-2 groups: Type 1 and Type 2
--Type 2 is associated with hemorrhagic syndrome and thrombocytopenia
--both are cytopathic
-Can cause acute infections or more chronic mucosal disease from persistent infection
-Persistently infected animals continuously shed viruses for life
--never clear the virus
-Prone to secondary bacterial infections
-Vertical and horizontal transmission
Cytopathic BVDV
-Cause destruction of cells, lysis of cells in cell culture
-Cause cell death
Vertical transmission of BVDV
-From mother to offspring
-Allows for persistent infection
BVDV mucosal disease
-Devastating erosion of the intestinal lining
-Characterized by fever, depression, profuse watery diarrhea
-Erosive lesions in mouth, on foot pads, in intestine
-Typically low WBC counts
-Animals become progressively weak or dehydrated, succumb to infection within 5-7 days
-Non-cytopathic version of virus can mutate and become cytopathic
--leads to mucosal disease
Pathogenesis of BVDV in cattle
Pregnant animal is infected with non-cytopathic biotype
-Fetus is infected day 40-125 of gestation
-Fetus recognizes viral antigen as "self" and will not react to virus
-MAJOR problem! Source of virus shed!

Can be born with persistent infection
Development of BVDV mucosal disease
1. Mutation of a non-cytopathic version of virus to a cytopathic version
-Specific mutation event gives rise to new viral protein
2. infected from cytopathic virus from external environment
Prevention of BVDV herd infection
1. Monitoring: test all new animals introduced into the herd
-Blood tests to identify persistently infected animals
2. Biosecurity: quarantine new animals until test results are known
3. Vaccination: tough, many strains of the virus and many mutations
-no vaccines are very good
Treatment and control of BVDV
-Prevent infections!
-Prevent birth of presistenly infected animals
-Cannot treat animals with mucosal disease
-Vaccine have been developed, but are not that effective
-remove persistently infected animals from the herd!!
Hog Cholera Virus
-Pestivirus
-Economically important
-Extremely contagious disease
-Eradicated in the US
-Virus enters oronasal route
--tonsils are primary site of viral replication
-Acute infection that results in systemic spread of virus
-Has been eradicated by many countries
Hog Cholera prevention and control
-Reportable disease
-Restrictions are important for trade and export
-Many countries have a slaughter and eradication procedure
-Live-attenuated vaccines have been developed
-Marker vaccines to get around DIVA have been developed
--helped in eradication
Arboviruses
-Arthropod-borne viruses
-West Nile Virus
-Togavirus
-EEE, WEE, VEE
West Nile Virus
-First detected in birds in 1999
-Maintained in bird-mosquito cycle, transmitted via bite of an infected mosquito
-Endemic in the US
-Has spread across US over 10-15 years
-Can cause encephalitis in equines and humans
-Clinical signs range from fever to death
-Severe cases of encephalitis are RARE
--linked to immunocompromised individuals
-No human vaccine
-Inactivated vaccines for horses
-Control mosquito population!
West Nile Virus Vaccines for Horses
1. Innovator: inavtivated whole-virus vaccine
2. PrevNile: yello fever chimeric vaccine
3. Recomniteck: recombinant canarypox-vectored WNV vaccine
-Used DNA virus as a vector to express WNV proteins
4. Vetera: killed WNV vaccine
Togaviruses
-Arborvirus
-Spherical, enveloped virion with icosahedral capsid
-Alphaviruses: in animals
-linear, +sense single-stranded RNA virus
-Polyprotein encodes structural and non-structural proteins
-Cytoplasmic replication, virus buds from the plasma membrane
Eastern Equine Encephalitis
-East of Mississippi
-Transmitted by mosquito
-Equine host
-Encephalitic disease is rare
Western Equine Encephalitis
-In Western US
-Transmitted by mosquito
-Equine Host
-Encephalitic disease is rare
Venezuelan Equine Encephalitis
-In South America and SE USA
-transmitted by mosquito
-Equine Host
-Encephalitic disease is rare
Clinical features of EEE, WEE, VEE
-Infections often lead to sub-clinical febrile disease or neurological disease
-EEE is most severe in horses and humans
-High titer of virus during secondary viremia can be transmitted back to mosquito (rare)
-Severe depression, wide stance, hanging head, wandering, impaired vision, photophobia, constant head pressing
-Animals can recover but will have neurological sequelae
--dementia, paralysis
-Inactivated vaccines exist but need boosters
-Immunity from natural infection appears to be life-long
Transmission cycle of EEE
-Aggressive mosquito transmission
-Wild birds and mosquitoes are the "endemic" cycle
-Horses and humans are dead-end hosts
--not required for progression/continuation of the virus in nature
EEE in the USA
-Neuroinvasive disease in humans is prevalent in the southeast
-Swampy, marshy areas of the state
-Usually outbreaks in horses precedes outbreaks in humans
WEE transmission cycle
-Virus is maintained in a bird/mosquito cycle
-Specific birds and mosquito species can vary
-Humans and horses are dead-end hosts
Pathogenesis for Alphavirus and Flavivirus infections
1. Arthropod bite, introduced by mosquito
-mosquito injects the virus into the bloodstream where it cab begin to replicate
2. Primary viremia, virus is in the blood and replicates
-virus is often cleared in immunocompetent individuals
3. Secondary viremia in immunocompromised hosts
4. Virus spreads to target organs via bloodstream
-CNS is target organ for EEE, WEE, an d VEE
-Other viruses target other organs

Subclinical infection: Virus is removed by the reticuloendothelial system
-Virus may be cleared or may spread
-Amount of virus in the blood and duration of viremia varies
Coronaviruses
-Large, pleomorphic, enveloped virion
-Large club-shaped peploers
-Linear, positive-sense single-stranded RNA genome
--one of largest RNA genomes
-Infectious RNA replicates in the cytoplasm
-Buds into the golgi apparatus of the cell to acquire envelope
--released from cell via exocytosis
-Has a "crown"
Coroniavirus Replication
-Endocytosed into the cell
-1st step is translation (+sense RNA)
--Only translate 5' most-protein to begin with
-Transcribe a -sense copy of the genome
--forms a -sense "nested set" of the mRNA
--all other viral proteins are translated from nested set
-Replicate in the cytoplasm
-Do not bud from the plasma membrane, are exocytosed from the cell
Unique features of Coronavirus
1. Exocytosed from the cell, does not bud from plasma membrane
2. Forms a 3' nested set of mRNA transcripts that viral proteins are made from
Coronaviruses of Veterinary importance
-Feline Coronavirus
-Transmissible gastro-enteritis virus
-Infectious bronchitis virus
-Turkey coronavirus
-Bovine coronavirus
-Canine coronavirus
Feline Coronavirus
-Has a mutated version that gives rise to Feline Infectious Peritonitis virus
Transmissible Gastroenteritis virus
-Highly contagious in piglets
-Causes vomiting, profuse yellowish diarrhea, weight loss, dehydration
-high morality in piglets
--more susceptible due to inefficient gastric secretions to inactivate the virus and milk diet will buffer secretions
-Enters body by ingestion
-Clinical signs begin 18-72 hours
-Attenuated vaccine is not effective
-need to control with management
Porcine Epidemic Diarrhea Virus
-New virus!
-Coronavirus similar to Transmissible Gastroenteritis virus
-Fecal-oral transmission, also fomites
-Widespread in europe
-Enveloped virus, but stable under certain conditions
-Virus damages villi in small intestine
-Fluid loss, dehydration, diarrhea
-HIGHLY contagious
-40% mortality
-Can be identified by ELISA
-Not zoonotic
Feline Infectious Peritonitis
-Mutation of Feline enteric Coronavirus
-Severe systemic disease in cats
-Progressive, debilitating, lethal disease in wild and domestic cats
-Usually associated with immunosuppressed animals
-Anorexia, chronic fever, malaise, neurological symptoms sometimes
-Virus infects and replicates in monocytes and macrophages
--extensive tissue damage to immune-complex formation
-Immune Enhancement allows virus get into cells
-Live-attenuated vaccine applied to nasal mucosa
--allows low-level viral replication
--favors induction of cell-mediated immunity, some protection is achieved
Immune Enhancement
-Non-neutralizing Antibodies bind to the surface glycoprotein of the virus
-Virus-antibody complexes are readily taken up by macrophages via Fc receptors
-Worsens disease, helps virus get into cells
-Little old lady taxi example
FIP pathology
1. FIP viral replication in the macrophages
2. B-cells are activated, produce non-protective antibodies
3. Immune complexes form in circulation
4. Causes immune-mediated vasculitis, worsens disease

Wet FIP: effusive form with vascular permeability abd swelling in abdominal cavity
-fast death

Dry FIP: non-effusive, progressively fatal, slower death
Avian Infectious Bronchitis
-Highly transmissible respiratory disease of Poultry
-"Gasping disease"
-Affects respiratory cells in trachea and bronchi
-Virus replicates in ciliated epithelial cells, spreads to many organs
-Outbreaks can be explosive, highly contagious
-Thickened mucosal membranes, serous exudate in nasal passages, trachea, and bronchi
-Vaccine exists, given in drinking water
Severe Acute Respiratory Syndrome
SARS
-Coronavirus
-Viral respiratory illness
-Spread person to person, respiratory route
-Flu-like symptoms, often leads to pneumonia
-No specific treatments or vaccines currently
-Origin of virus is unclear
--species jumper? close contact between humans and animals
Arteriviridae general properties
-Coronavirus related virus family
-Enveloped virions with icosahedral capsid
-single linear +sense single-stranded RNA
-Replicates in cytoplasm and forms nested set of translation
-Virions bud from the ER into intracellular vesicles, released from cell via exocytosis
-Ex: Porcine respiratory and reproductive syndrome virus, Equine Arteritis virus
Porcine Respiratory and reproductive Syndrome Virus
PRRS
-Arterivirus, coronavirus
-First emerged in US in 1987
-Leads to reproduction issues, stillbirths, abortions
-Economically important disease of wild and domesticated pigs
-Anorexia, fever, blue discoloration of snout and ears, abortions, stillbirths
-Pneumonia in piglets
-Virus can spread quickly via aerosol, contact, semen
-Relatively stable enveloped virus
-Highly infectious
PRRS Pathogenesis
-targets pulmonary macrophages
-Early antibody response is not able to clear virus
-Immune enhancement promotes viral efficacy
--production of non-neutralizing antibodies
--worsens disease, allows virus to get into macrophages
-Spreads throughout the body in macrophages, replicates in macrophages
-Spreads across the placenta and affects the fetus
-Live and killed vaccines exist
Reoviruses
-Respiratory Enteric Orphan virus
-First identified in rodents
-Non-enveloped, spherical virions with 3 concentric capsid layers
-Have segments of double-stranded RNA
-Bluetongue, rotavirus
-5' cap on the +sense RNA strand only and no poly A tail
-Infectious subviral particles are formed when outer capsid is removed
-Replicates in the cytoplasm
-Only partially uncoats for replication
Reovirus replication
-Divided into 2 phases
-Replicates in the cytoplasm
-Only partially uncoats for replication
-Early transcription and late stage of transcription
-Genetic/RNA re-assortment can occur
--swapping of genes between different reoviruses
--important for pathogenesis
Reovirus Capsid Layers
-3 capsid layers on top of each other
-Outer capsid: infectious particle
-Middle capsid: ISVP
--still infectious
-Inner capsid: core, non-infectious
--Double-stranded segments of RNA sit in the core and never really leave
--mRNA come out of pores into cytoplasm but genomic RNA stays in core
Bluetongue Disease
-Reovirus, orbivirus
-Affects sheep and cattle, significant virus
-Transmitted by biting midges, biting flies
--Arthropod borne virus
-Hematopoietic and endothelial blood cells are main targets
--replicates and destroys endothelial cells
--destruction leads to "blueing"
-Outbreaks in US and UK
-Fever, loss of body condition, ulcers in mouth, hemorrhage, lameness, blue/purple tongue, abortions and congenital malformations
Rotavirus Infection
-Reovirus
-widespread, can affect every mammal
-Cause severe diarrhea, esp in young animals
--"milk scours"
-Viral factories, can see dense accumulations of viral replication
-Infection leads to destruction of epithelial cells on villi in small intestine
-Replicate to EXTREMELY high titers, TONS of viral particles excreted per gram of feces
-Can lead to secondary bacterial infections
--E. coli and Salmonella
Human Rotavirus vaccines
-Contravertial vaccine
-Oral, tetravalent recombinant vaccine
--Mix and match rotaviral segments
-Reassortment technique for vaccines
Retroviridae Properties
-Enveloped virus, fairly large particle
-Icosahedral and helical capsid
-2 copies of +sense RNA genome (diploid genome)
-Only +sense RNA virus where 1st step is NOT translation
--1st step is conversion of +sense RNA into double-stranded DNA
-Goes from RNA back into DNA, hence "retroviridae"
Unique feature of the Retroviridae Family
-Start with viral RNA, converted into double-stranded DNA, then forms viral mRNA and RNA genome
-Completed via reverse transcriptase
-DNA integrates into host genome, acts as integrated DNA protein
--host cell machinery is used to express viral RNA
Types of Retroviruses
-A-type: non-enveloped, immature particles present in the cell
-B-type: enveloped, extracellular particles with a condensed, acentric core and prominent spike proteins
-C-type: enveloped, estracellular particles with a central core, barely visible spike proteins
-D-type: largest particles, spike-less
Key Retrovirion properties
1. Enveloped virions
2. Contains reverse transcriptase, carried in with virus
3. Genome is diploid, 2 copies of +sense ssRNA
-Only example of diploid viral genome
4. Only viral RNA synthesized and processed by host cell mRNA processing machinery
5. Only genome to be associated withspecific tRNA
6. Only +sense RNA virus that does not form mRNA right after infection
7. Contains reverse transcriptase!
Reverse Transcriptase
-Carried along with retroviruses
-RNA-dependent DNA polymerase function
--converts RNA into DNA
-DNA-dependent DNA polymerase function
--converts DNA into DNA to make double-stranded DNA
-integrasae function
--allows insertion into host chromosome
-RNAse function
--Degrades RNA template
Retroviral Proteins
1. GAG gene: Group-specific antigen
--Internal proteins/structural proteins of the virus
--Matrix protein, capsid protein, and nucleocapsid protein, protease itself
2. POL gene: polymerase
--reverse transcriptase and integrase
3. Envelope gene: encodes for surface protein ad transmembrane protein
Retrovirus Replication
1. Attachment to specific cellular receptor
2. Penetration
--some fuse at plasma membrane, others are endocytosed
3. Reverse transcriptase to form double-stranded DNA
4. Entry of DNA to nucleus via nuclear pores
5. Incorporation of DNA into chromosome of the cell
--provirus
6. Host cell transcription, translation, and replication
7. Packaging of newly-made viral proteins and budding
8. Processing of newly-made proteins does not occur until virus has budded away from the cell
--cleavage and maturation within the viral particle
Provirus
-integrated DNA genome of retrovirus in host cell genome
Characteristics of Cells transformed by Viruses
1. Viral DNA sequences are present either integrated into cellular DNA as provirus or as episomes
2. Transformed cells have a greater growth potential
-Lose contact inhibition, can divide infinitely in culture
-can grow in suspension or semi-solid agar
3. Altered cell morphology
4. Altered cell metabolism and membrane changes
5. Chromosomal abnormalities
6. Virus-specific tumor associated antigens
7. Capacity to produce malignant neoplasms when innoculated into immunosuppressed animals
Oncogene
-Has potential to cause transformation/tumors
-Can be protoncogene
-V-onc is a viral oncogene
--All are derived from cellular genes, cellular genes are incorporated into cellular genome
--transported along with virus whenever it buds and goes to other cells
--Levels can be over-expressed in viruses
-C-onc is a cellular chromosome oncogene
Retroviral induction of oncogenes
-Virus carries cellular oncogene with it to other cells
-Induces gene to replicate more than it would normally
-Can become cancerous
C-onc genes
-Transcriptional activators or repressors
--bind to promoters
-Receptors, especially for growth factors
-Growth factors
-Protein kinases
-Intracellular signal transducers
Control of cell growth
-Growth factors: bind to growth-factor receptors
--set off series of signaling events that end up with expression of genes
-Can lead to transformation of cell
-Abnormal gene expression leads to cell transformation
Oncornavirus Genome Structure
-RNA virus carrying a potential oncogene in addition to normal viral protein genes
-Results in over-expression of protein, now under control of viral promoters
--viral promoters in Long-terminal repeat sequences
-LTR regions are strong promoter and enhancer elements
--Drive expression of normal viral proteins AND incorporated oncogene
--over-express oncogene and rapidly leads to transformation
Retrovirus Oncogenes
V-onc
-Not essential for virus replication
-Extra gene for the virus
-Acquired over time by viruses
-Allows virus to get cell to grow and divide uncntrollably
--allows spread of virus
Replication defective oncoviruses
-Virus picks up C-onc, but in the process looses a portion of the normal viral genome
-Lost essential genes in recombination event
-Virus is now "replication defective"
--cannot produce all of the proteins it needs to replicate
-Requires a helper virus with complete polymerase gene
-"Hitchikers"
Mechanisms of Retrovirus oncogenicity
1. Transducing retroviruses
2. cis-activating retroviruses
3. trans-activating retroviruses
4. Inactivation of tumor-suppressor genes
Transducing retroviruses
-Retroviruses that contain an oncogege, carry in cell-derived oncogene as part of genome
-Often replication defective
-Can transform cells rapidly, bring in potential oncogene with it
Cis-activating retroviruses
-High efficiency of tumor formation
-C-Onc is not carried by viral genome
-Integration of v-onc occurs right next to a c-onc in the host chromosome
-LTR of retrovirus causes over-expression of host protein
--leads to up-regulation and transformation of C-onc
Trans-activating retroviruses
-Rare
-Carry additional viral proteins that act as transcriptional activators
-Carry in accessory proteins
-Proteins can bind to cellular promoters to enhance promotion
-Viral-encoded regulatory proteins
-Turna on viral protein expression and host-cell expression
Inactivation of tumor-suppressor genes by retroviruses
-Viral genome inserts in the middle of tumor-suppressor genes
-No signal to tell cell to stop dividing
-Cell divides indefinitely
Viral genome without Onc gene
-No transformation of cells in culture
-Low efficiency for tumor production
-Prolonged latent period until tumors develop
-Leukemia viruses
Viral genome with Onc gene
-Can be replication competent (replicates on own)
--avian sarcoma virus
-Replication defective, needs helper virus
-Rapidly transform cells, rapidly induces tumors
-Animals infected by virus are likely to develop tumors
Endogenous retroviruses
-Retroviruses that are inserted into the chromosome of the host genome
-Usually vertical transmission
-Considered to be dormant
-Typically not activated, rarely form tumors
-Defective pieces often, remnants of retroviral insertion
Exogenous retroviruses
-Come from nature
-Can infect the host
-Can be slow-transforming or rapidly-transforming
Avian Leukosis virus
-Endemic in all flocks of chickens
-Most chickens will become infected within a few months of hatching
-Have bred resistant flocks, lack receptor for virus
-Horizontal and vertical transmission
--vertical transmission was the major problem
-Proviral DNA is integrated, activates c-onc
-Defective viruses arise and are often rapidly fatal
Horizontal and vertical transmission of Avian Leukosis Virus
-Bird to bird horizontally
-Vertical transmission via congenital infection or genetic transmission
-Chick develops tolerance to the virus, will not mount an immune response
--chances of developing leukemia are high
-Can be passed in germ line to eggs and chicks
Feline Leukemia Virus
-Oncornavirus
-Replication competent, has Gag, Pol, Envelope
-Does not carry and oncogene
-Induces leukemia or lymphosarcomas
--slow, rare event
--not rapidly transforming
-Cannot infect other species
-Endemic worldwide
-1-7% of cats in US are infected
-Causes immune suppression, weakens immune system
--many cancer deaths in cats
Feline Sarcoma Virus
-Replication defective form of FeLV
-Has lost Pol, picked up FMS oncogene
-Rapidly causes transformation and fibrosarcomas
-ALWAYS transmitted with FeLV, cannot infect on own
--needs envelope glycoprotein or polymerase from FeLV to be transmitted and infectious
Feline Immunodeficiency Virus
-Lentivirus
-replication competent, but does not cause tumors
-Causes immunodeficiency disease
FeLV pathogenesis
-Healthy cat is infected, can mount immune response and recover
--self-limiting infection
-Can get into bloodstream and replicate to high levels
--Primary viremia
-Persistent infection causes persistent viremia for months
--usually ends with leukemia virus related disease
-Cats shed virus in secretions and saliva
-Spread by grooming or biting
FeLV diagnostic testing and control
-ELISA/Snap test exists
--tests against GAG antigen of virus
-Vaccines exist, inactivated vaccines
--only 70% effective
FeLV vs FIV
-85% of infections are due to FeLV/FSV, rest are FIV
-FIV does not cause neoplasia, but does cause immunodeficiency
--lentivirus
-Both are labile, enveloped virus, easily inactivated
-FeLV can be transmitted vertically in-utero or in milk
-FIV is not transmitted by milk or in-utero
-FIV is more cell-associated, harder to transmit
--found in saliva, biting is major route of spread
-FeLV is spread by grooming, fleas, biting
Lentiviruses
-Slow, persistent retroviruses
-EIA: causes life-long infection, no vaccine
-Caprine arthritis-encephalitis
Equine Infectious Anemia Virus
-Initially infects macrophages, then lymphocytes
-In acute disease: fever, anemia, weakness, blood-stained feces
-80% of cases can be fatal
-recovery is possible, but will have life-long persistent infection
--may have recurrent episodes
-Life-long cell-associated viremia
-Coggins test
-Transmitted from horse to horse via stable flies or horse flies
--higher transmission in summer
-Virus does not survive very long within vector, has 30 min/1 hour to transmit virus
Coggins Test for EIA
-Agar Gel Immunodiffusion (AGID)
-Center well is loaded with viral antigen
-Blood sample and antigen migrate through the gel
-Positive recaction (antibody recognizes antigen), get precipitant line
--indicates infection
Caprine Arthritis-Encephalomyelitis
CAE
-Lentivirus that affects goats
-Economically important disease
-2 possible syndromes
--Encephalomyelitis in kids, 2-4 months
--arthritis in older goats
-Acquired via colostrum or milk
-Rate of infection can be reduced by removing kids from does as soon as they pass through birth canal
-Can do coggins test to test for disease
Retroviruses in reptiles
-Inclusion body disease
-Disease is terminal in animals that exhibit clinical signs
-Can have asymptomatic carriers
-Neurological symptoms with paralysis, CNS disorders
-"Star gazing," reflexes are gone
-Thought to be associated with type C endogenous retrovirus, still unknown
Fish over the last century
-Biomass over the last 100 years has decreased dramatically!
-Fishing has stayed the same
-We are running out of fish
-80% of world's fish catch species have been exploited beyond or close to harvest capacity
Cod in Newfoundland Grand Banks
-Early 1990 collapse due to over-fishing
-Have not yet recovered a decade later
Dramatic decline of fish worldwide
-Large predatory fish in oceans has dropped by 90%
-Dramatic decline in trophy fish size in key west
-Large predatory fish weight has declined 88%
-Average length of sharks has declined 50%
-Seafood faces total collapse by 2048
Fish Farming
-Has allowed humans to maintain fish intake
-1 out of every 2 fish consumed are farmed
-2 million tons of extra fish will be required annually for the next 30 years
-More than 1/3 of fish in farms do not reach marketable size
--results in $9 billion in losses for industry
--More than 80% are lost to diseases
Sustainable fish farming
-Solution to fish issue?
-Massive scale farming leads to contamination of area and watersheds
Ornamental fish
-US is single largest importer of ornamental fish in the world
-Corals and marine aquarium business is booming
-Lots of illegal trade for ornamental fish
-Aquarium industry is over $1 billion in US
Disease state of fish
-Occurs through interactions of the host, pathogen, and environment
Conditions influencing fish health and infectious disease
-Physiological status of the fish
--natural resistance to bugs
-Vaccinatino
-Host species
-Host age
-Husbandry, how clean the facilities are
-Environment
-Attrition
--huge area of research
-Correct nutrition can increase fish immune system
-Pathogen itself
Farming fish stresses fish
-Cows have had time to get used to farming
-Fish farming is relatively new, only last 20-100 years
-Fish get stressed! They are still really wild animals!
-Immune function is depressed when fish are stressed
--allows infection with important bacteria
Fish stress and Disease
-Immune system is depressed when fish are stressed
-HPA axis is activated
--leads to release of catecholamines and cortisol
-High amounts of cortisol leads to immune system depression
-Opportunistic organisms can come in and kill animals
Fish Bacterial diseases
-Most prominent group of fish diseases
-Frunculosis
Frunculosis
Aeromonas salmonicida
-Oldest and most well-studied disease
-Still very prevalent
-Have vaccines that will prevent disease
-Caused by Aeromonas salmonicida
-Presents as ulcers in skin of the fish
--Extensive hemorrhage in the muscle of the fish when the bacteria goes through the skin
--Ascites
Aeromonas salmonicida
-Gram- bacteria
-Causes frunculosis in fish
-Has 2 types of virulent factors
--A-layer (proteins that cover bacteria)
--Extracellular products (toxins and proteases)
Aeromonas salmonicida vs. Aeromonas hydrophilla
-A. salmonicida is much more pathogenic
-Can compare on culture
--A. salmonicida produces pigment
Aeromonas salmonicida extracellular products
-Virulence factor
-Toxins and proteases
-Damage the skin and muscle of the fish
-Host neutralizes extracellular products with alpha-2-macroglobulin and complement
Fish species infected by Aeromonas salmonicida
-LOTS of fish species
-Eel
-Minnow
-Carp
-Catfish
-Cod
Aeromonas salmonicida diagnosis
-Lots of ways to identify bacteria
-best way is to do a serological test (ELISA)
-Can do a PCR
Furunculosis Treatment
-Antibiotics
-Resistance exists
--plasma-mediated and mutational drug resistance
Furunculosis Vaccine
-2 vaccines exist
-Adjuvant needs to be made out of oil to be effective
-Vaccines do not provide protection against all strains of A. salmonicida
--atypical A. salmonicida
Enteric red-mouth disease
-Disease of fish
-Causes hemorrhage in the operculum
-Also causes splenomegaly and hemorrhage within the viscera
-Caused by Yersinia Ruckeri
-Mostly affects salmonid species
-
Yersinia ruckeri
-Gram- bacteria
-Causes Enteric red-mouth disease in fish
-Affects a wide-range of salmonid species and other fish species
-Virulence is associated with a plasmid
-Treat with antibiotics
-Control with vaccines, can induce cell-mediated immunity
--induces IgT mucosal fish antibody
Columnaris disease
-Becoming more widespread
-Does not kill animals, leaves animals with lesions
--animal can have massive lesions and still survive
--cannot sell fish with lesions
-Caused by Flexibacter columnaris
-Mostly an epithelial disease, lesions are on skin of animal
-Affects salmonids and other species of fish
-Treat with antibiotics
-Vaccine is experimental, not available on market yet
Flexibacter columnaris
-Gram- bacteria
-Elongated bacterial filaments
-Unknown virulence factors
--secretes a lot of Extracellular products, but not sure what they do
-Susceptible to classical complement pathway, but not the alternate complement pathway
Enteric Septicemia of Fish
-Important for catfish
--most widely farmed fish in the US
-Caused by Edwarsiella ictaluri bacteria
-High seasonal occurrence
--highest May-June and September-October
--Correlates with favorable water temps
-Most important disease affecting catfish
-Acute form of the disease induces necrosis of the spleen and liver
-Chronic form is characterized by nasal ulcer
-Vaccine is available but not 100% effective
--injectable disease
-bacteria is susceptible to Classic Complement Pathway
Bacterial Kidney Disease
-Caused by Renibacterium salmonimarum
-Granuloma formation in the kidney
-No bacteria are available
Bacterial Cold water disease
-Caused by some bizarre, no-slide bacteria
-Forms yellow
-Bacteria shows up when the water is cold (15C)
-In small fish: "Rainbow Trout Fry Syndrome"
-Different pathogenicity in adult and small fish
-Mostly an epithelial disease
-Vaccines are not available
-IgT is main immunoglobulin in skin that is induced
Edwarsiella ictaluri
-Gram- bacteria
-Causes Enteric Septicemia of catfish
-High seasonal occurrence in May-June and September-October
Renibacterium salmonimarum
-Causes bacterial kidney disease
-Intracellular gram- bacteria
-Induces granulomas
-Can see lesions in the kidney
-VERY harmful
--induces hemolytic, proteolytic, exotoxin, catalase, and DNAse activities
--Penetrates skin and goes systemic
-P57 major virulence factor
--promotes intracellular invasion of leukocytes
--Induces immunosuppression
Intracellular pathogens and Vaccines
-Common that vaccines do not exist
Vibriosis
-Induced by Vibrio anguilarum and Vibrio salmonicida
-Produce skin lesions on abdominal area
--location on abdomen is indicative of Vibrio infection
-Affects many different fish species
-Occurs with sudden changes in the water temperature
-Vaccine exists, but is not always cost-effective
Vibrio anguilarum
-Gram- bacteria
-Affects both fresh and salt water fish
--affects many different fish species
-Can attack immunosuppressed fish during sudden changes in water temperature
-Secretes very virulent/lethal Extracellular products
--ECPs agglutinate fish RBCs
-Vaccine exists but is not always cost-effective
Viral Fish Diseases
-Prevalent, but not as prevalent as bacterial fish diseases
-Infectious Hematopoietic Necrosis Virus (IHNV)
Infectious Hematopoietic Necrosis Virus
IHNV
-Fish virus
-"Ebola of the fish"
-Can kill fish in 3 days
-Mainly affects small fish (Fry)
--Salmonid species
-Causes hemorrhage in the skin of the fish
-Can cause scoliosis
-Will see thick trailing fecal cast in affected animals
-VERY deadly
-No commercial vaccines available
-Immunization of fish with IHNV induces neutralizing antibodies
Life cycle of IHNV
-Can be transmitted horizontally between small fish
-Can be transmitted vertically from adult to egg
Viral hemorrhagic Septicemia Virus
VHSV
-Very similar to IHNV
-Mostly affects salmonids
-Can see bilateral exopthalmos, eyes protrude from the head
-Lots of hemorrhage everywhere in the body
-Causes marked kidney necrosis
-Lots of loss of hematopoietic cells
-No commercial vaccines available
DNA vaccine for IHNV
-First commercially available DNA vaccine! very exciting
-Used in fish
Koi Herpesvirus
KHV
-DNA virus in herpesvirus family
-Not a zoonotic disease
-Affects carp and ornamental variants like Koi
-Has led to HUGE mortality in fish
-Highly contagious
--90% prevalence in carp populations
-Identify virus with cell tissue culture and PCR
Koi Herpesvirus signs of disease
-lethargy
-erratic swimming behavior
-Increased mucus production
-Hemorrhage in liver
-Gill necrosis
Fungal diseases in Fish
-Oomycetes "water molds"
Saprolegnia
-Water mold/fungal disease of fish
-Not primary pathogens, opportunistic and attack diseased fish
--immunosuppressed fish
-Can consume a fish within a few days
-Fish can be swimming around with half of body covered
--kills fish slowly, suffer a lot
-induce lymphocytopenia and impair hematopoietic organs
-No vaccines available
--treatment with malachite green or 0.5% NaCl
Persistent UTI
-Bacteruria with the same organism that continues during therapy with appropriate microbial agent
Relapsing UTI
-Infection with the same microorganism that recurs within several weeks of end of microbial therapy
-Bacteria "hides" and comes back when antimicrobials are gone
UTI Reinfection
-Infection with initial microorganism responds to therapy
-Infection by a different agent occurs weeks to months after the course of antibiotic therapy
-Common with older dogs or animals that are susceptible to something else
-Continual new infections due to weak immune system in urinary tract
UTI Superinfection
-Infection with new organisms develop during the therapy for the initial organism
-Usually associated with an in-dwelling catheter
-Can be due to severe anatomic abnormalities or surgical diversion techniques
Simple-uncomplicated UTI
-No underlying structural or functional abnormality suspected
-Resolved with therapy and fine afterwards
Complicated UTI
-Infection is associated with structural or functional abnormalities within the urinary tract
-Animal may have impaired immunocompetence
-Will have continued infection of the animal
Prevalence of Bacteriuria
men vs. women
-Early on in life women are slightly higher
-At puberty, women are MUCH more likely to get UTI
-At around 50, men start having more UTIs
-Same prevalence around age 70

Length of the urethra is the main issue, shorter length in women
Very similar to dogs
UTI bacteria in dogs
Outpatients
-E. coli: 80%
-Staphylococcus: 7%
-Proteus mirabilis: 6%
-Gram- bacteria: 4%
-Other gram+ bacteria: 3%
UTI bacteria in dogs
Inpatients
-E.coli: 44%
-Enterococci: 13%
-Staphylococcus intermedius: 12%
-Proteus mirabilis: 9%
-Klebsiella: 10%
-Pseudomonas: less than 5%

-Much more gram- bacteria due to antibiotic resistance
Bacterial attributes contributing to UTI
-Capsular antigens
-Hemolysins
-Urease
-Adhesion to uroepithelium
-Toxins
-Iron uptake systems
-Adhesion to uroepithelium
-Introital colonization
Host factors contributing to UTI
-Renal calculi
-Ureteric reflux
-Tumors in and adjacent to the urinary tract
-Pregnancy, bladder stones
-Neurological problems
--incomplete emptying, loss of sphincter control
-Prostatic hypertrophy
-Short urethra in women and dogs
-Catheterization
Neutrophil migration during UTI
-PMN in urine indicates infection
--should not normally be there
-Part of an active inflammatory response
-Neutrophils follow chemotactic gradient to epithelial surface and cross epithelium
--go from vasculature into tissue
-Neutrophils phagocytose bacteria in urinary tract
-Dead neutrophils go into the lumen and release mediators
Uropathogenic E. coli
-Intracellular bacterial community that is particularly pathogenic for the urinary tract
-Uropathogenic E. coli with type 1 pilli attach to epithelial surface and invade cells
-Bacteria replicates within the cells, form intracellular bacterial community
-Desquamination of epithelial cells allows bacteria to colonize deeper tissues
-Cells exfoliate and bacterial communites and neutrophils are put into lumen
Bacterial Biofilms and UTI
-Common cause of persistent infections
-Differentiated structured groups of cells with community properties
-Bacteria do not just float around, stick to surfaces
-Aggregate in hydrated polymeric matrix to form biofilm
-root of many persistent and chronic bacterial infections
Intracellular bacterial communities and UTI
-Formation is similar to biofilms
Biofilm Production and Maturation
1. Attachment and EPS production
2. Dearly development of the biofilm
3. Maturation of the biofilm
4. Dispersion of the bacteria within the biofilm
Intracellular bacterial community production and maturation
1. Colonization and invasion of cell
2. Early IBC, rapid intracellular growth
3. Mid IBC, change to biofilm-like properties
4. Late IBC, fluxing out and filamentation
Entry points for bacteria in a catheter system
-Urethra meatus and around the catheter
-Junction between the catheter and collection tube
-Connection to drainage
-Reflux from bag to tubing
Guidelines for Catheter Care
-Avoid catheterization whenever possible
-Minimize catheter duration
-Use intermittently if possible
-Use good aseptic technique when placing
-Use closed sterile drainage system
-Maintain gravity drain
-Use topical antiseptics around meatus in women
-Wash hands before and after inserting catheters and collecting specimens, and after emptying drainage bags
Percent of patients with bacteriuria
-Very minimal with bladder aspiration
-Highest with clean catch, more contaminated
-"Sweet spot" of 10x10^5 for bacteria
Ampicillin and Amoxycillin for UTI
-Oral antibacterials
-Beta-lactams
-More than 50% of gram- rods causing UTI are beta-lactamase producers
--beta-lactams are not effective
-Maybe not the best choice
Augmentin for UTI
-Oral antimicrobial
-Betalactam and beta-lactmase inhibitor
-Active against most gram- rods that are resistant to ampicillin due to beta-lactamase production
Cephalexin and Cefaclor for UTI
-Beta-lactam
-Relatively beta-lactamase stable
-Have wider spectrum than ampicillin
-Not active against enterococci
Trimethoprim for UTI
-Nucleic-acid synthesis inhibitor
-Increasing incidences of resistant strains
Cotrimoxazole
-Oral antibiotic for UTI
-Urinary antiseptic
-Used for complicated UTI only
-Not active in alkaline pH, therefore not useful for proteus infections
Nalidixic acid
-Oral antimicrobial for UTI
-Quinolone
-For uncomplicated UTI
-Gram- infections only
-Not active against gram+ bacteria
Ciprofloxacin
-Antimicrobial used for UTI
-Fluoroquinolone
-Very broad spectrum antibiotic
-Only oral agent active against pseudomonas aeruginosa
-Not active against enterococci
Antibiotic treatment for UTI
-Antibiotic must be secreted in the active form into urine, otherwise ineffective
-Kidney needs to be functioning
How to treat UTI
1. Acidic urine:
-Rods= E.coli, treat with Trimethoprim or Enrofloxacin
-Cocci= Enterococci, Streptococci, treat with Apicillin or Amoxicillin
2. Alkaline urine:
-Rods= Proteus mirabilis, treat with Ampicillin or Amoxicillin
-Cocci= Staphylococci, treat with Cephalexin or Amoxicillin-clavulanate
Antimicrobial Tx for E. Coli UTI
-Trimethoprim-sulfonamide
-Amoxicillin-clavulanate
-Fluoroquinolone
-Chloramphenicol
Antimicrobial Tx for Staphylococcus UTI
-Amoxicillin-clavulanate
-1st generation cephalosporins
Antimicrobial Tx for Streptococcus or Enterococcus UTI
-Ampicillin
-Amoxicillin
Antimicrobial Tx for Proteus mirabilis UTI
-Ampicillin
-Amoxicillin
Antimicrobial Tx for Pseudomonas UTI
-Tetracycline
-Fluoroquinolone
Antimicrobial Tx for Klebsiella UTI
-1st generation cephalosporins
-Trimethoprim-sulfonamide
-Amoxicillin-clavulanate
-Fluoroquinolone
Antimicrobial Tx for Enterbacter UTI
-Trimethoprim-sulfonamide
-Fluoroquinolone
Causes of persistent UTI
-Antimicrobial resistance
-Poor owner compliance
-Inadequate dosing
-Issue with the kidney
--inadequate urine concentration of antimicrobial
--poor absorption/secretion
-Inadequate drug penetration, wrong drug
Ascending UTI in dogs and cats
-E. coli
-Proteus
-Other coliforms
-Staphylococcus
Hematogenous nephritis in Dogs and Cats
-Leptospira with various serovars
-Vaccination status of the animal is important for Dx!
Ascending UTI in horses
-E. coli and coliforms
-Streptococcus
-Staphylococcus aureus
Hematogenous nephritis in Horses
-Actinobacillus equuli
-Leptospira of various serovars
Ascending UTI in Ruminants
-Corynebacterium renale with mixed flora
-Coliforms
Hematogenous nephritis in Ruminants
-Leptospira of various serovars
-Pyogenic bacteria
--gram+ cocci
--anaerobes
--Truperella pyrogenes
-E. coli
Ascending UTI in Swine
-Actinobaculum suis with mixed flora
--Eubacterium suis
-Coliforms
Hematogenous nephritis in Swine
-Erysipelothrix rhusiopathiae
-Leptospira of various serovars
-Pyogenic bacteria
--gram+ cocci
--anaerobes
--Truperella pyrogenes
-E. coli
Ascending/venereal Genital Tract Infections in Dogs
-Canine Herpes Virus
-Brucella canis
-E. coli and other coliforms
-Pseudomonas
-Streptococcus
-Staphylococcus
-Anaerobes
Hematogenous Genital Tract infections in Dogs
-Canine parvovirus
-E. coli and coliforms
-Streptococcus
Ascending/Venereal Genital Tract infections in Cats
-E. coli and coligorms
-Pseudomonas
-Streptococcus
-Staphylococcus
-Pseudomonas
-Anaerobes
Hematogenous Genital Tract infections in Cats
-Feline coronavirus/ FIP
-Feline retrovirus (FeLV)
-Feline parvovirus (Panleukopenia)
-E. coli and coliforms
-Streptococcus
Ascending/Venereal Genital Tract infections in Horses
-Equine Herpes virus 3
-Taylorella equigenitalis (CEM)
-Streptococcus (group C)
-Klebsiella pneumoniae
-Actinobacillus equuli
-Pseudomonas aeruginosa
-E. coli
-Anaerobes
Hematogenous Genital Tract infections in Horses
-Arterivirus (EVA)
-Equine Herpes virus 1 and 4
-Leptospira of various serotypes
-Salmonella abortusequi
Ascending/Venereal Genital Tract infections in Cattle
-Campylobacter fetus, venerealis
-Brucells abortus
--B. suis
--B. melitensis
-Anaerobes
Hematogenous Genital Tract infections in Cattle
-Orbivirus (Bluetongue)
-Pestivuris (BVD)
-Bovine herpes virus 1
-Brucella abortus
-Chalmydophila abortus
-Leptospira of various serotypes
-Listeria monocytogenes
-Salmonella dublin and other species
-Aspergillus fumigatus
Ascending Genital Tract infections in Sheep and Goats
-Brucella ovis
-Anaerobes
Hematogenous Genital tract infections in Sheep and goats
-Orbivirus (Bluetongue)
-Pestivirus (Border disease)
-Brucella melitensis and Brucell abortus
-Chalmydophila abortus
-Coxiella burnetii
-Leptospira of various serotypes
-Campylobacter fetus
-Campylobacter jejuni
-Salmonella abortusovis and other salmonella species
Ascending genital tract infections in Swine
-E. coli and coliforms
-Anaerobes
hematogenous Genital Tract infections in Swine
-Porcine Herpes virus 1, 2
-Pestivirus (classical swine fever)
-Porcine enteroviruses
-Porcine parvovirus
-Porcine arterivirus (PRRS)
-Brucella suis and Brucella abortus
-Leptospira of various serotypes
Major bacterial agents of Bovine Mastitis
-Staphylococcus
-Streptococcus agalactiae
-Streptococcus dysgalactiae
-Streptococcus uberis
-E. coli
-Klebsiella pneumoniae
-Enterpbacter aerogenes
-Truperella pyrogenes
Staphylococcus aureus Mastitis
-Lives in udder lesions and mucous membranes
-Causes subclinical, chronic, acute, and peracute mastitis
-Can cause gangrenous mastitis
-High percentage of subclinical carriers can occur within a herd
Streptococcus agalactiae Mastitis
-Hangs out in the milk ducts
--intramammary infection
-Causes acute or chronic mastitis
-Recurring clinical cases are common
-Infection can occur in maiden heifers
Streptococcus Dysgalactiae Mastitis
-Lives in the buccal cavity and genitalia of cattle
-Causes acute mastitis
Streptococcus uberis Mastitis
-Lives on skin, in tonsils, vagina, and feces of animals
-Causes acute mastitis
-Can cause mastitis during the dry period
E. coli, Klebsiella pneumoniae, and Enterobacter aerogenes Mastitis
-Live in feces, sawdust, and bedding
-Common in housed cows
-Coliform mastitis
-peracute toxemia
-usually occurs in fresh cows with low somatic cell counts
-Life threatening mastitis
-Little or no fibrosis of the udder will occur in recovered animals
Truperella pyrogenes Mastitis
-Lives on skin and mucous membranes
-Peracute, suppurative mastitis
"Summer Mastitis"
-Caused by Truperella pyrogenes, Peptostreptococcus indolicus, and occasional other anaerobes
--Part of normal flora
-Infection is thought to be fly-borne
-Most common in dry cows and heifers
-Foul-smelling udder secretions
-Loss of a quarter or death can occur